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Small non-coding RNAs have numerous biological functions in cell and are 
divided into different classes such as: microRNA, snoRNA, snRNA and siRNA. 
MicroRNA (miRNA) is the most studied non-coding RNA to date and is found 
in plants, animals and some viruses. miRNA with short sequences is involved in 
suppressing translation of target genes by binding to their mRNA post-
transcriptionally and silencing it. Their function besides silencing of the viral 
gene, can be oncogenic and therefore the cause of cancer. Hence, their roles are 
highlighted in human diseases, which increases the interest in using them as 
biomarkers and drug targets. One of the major problems to overcome is 
recognition of miRNA. Owing to a stable hairpin structure, chain invasion by 
conventional Watson-Crick base-pairing is difficult. One way to enhance the 
hybridization is exploitation of metal-ion mediated base-pairing, i. e. 
oligonucleotide probes that tightly bind a metal ions and are able to form a 
coordinative bonds between modified and natural nucleobases. This kind of 
metallo basepairs containing short modified oligonucleotides can also be useful 
for recognition of other RNA sequences containing hairpin-like structural 
motives, such as the TAR sequence of HIV. In addition, metal-ion-binding 
oligonucleotides will undoubtedly find applications in DNA-based 
nanotechnology. In this study, the 3,5-dimethylpyrazol-1-yl substituted purine 
derivatives were successfully incorporated within oligonucleotides, into either a 
terminal or non-terminal position. Among all of the modified oligonucleotides 
studied, a 2-(3,5-dimethylpyrazol-1-yl)-6-oxopurine base containing 
oligonucleotide was observed  to bind most efficiently  to their unmodified 
complementary sequences  in the presence of both Cu2+ or Zn2+. The 
oligonucleotide incorporating 2,6-bis(3,5-dimethylpyrazol-1-yl)purine base also 
markedly increased the stability of duplexes  in the presence of Cu2+ without 
losing the selectivity.  
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Pienillä ei-koodaavilla RNA-molekyyleillä, kuten microRNA, snoRNA, snRNA 
ja siRNA, on lukuisia biologisia toimintoja solussa.	 MicroRNA (miRNA) on 
eniten tutkittu ei-koodaava RNA. Sitä esiintyy sekä kasveissa, että eläimissä ja 
jopa viruksissa. Lyhyet miRNA-molekyylit estävät kohdegeenin ohjaaman 
proteiinisynteesin sitoutumalla geenin koodaamaan lähetti-RNA:han. Niiden 
toiminta voi, viraalisen geenin vaientaminen lisäksi, olla myös onkogeeninen ja 
siis jopa syöpää aiheuttava.	 miRNA:n yhteys	 ihmisen sairauksiin tekee niistä  
kiinnostavia biomarkkereita ja lääkekehityksen kohteita.	 Yksi suurimmista 
ongelmista on miRNA tunnistaminen. Koska niillä on pysyvä hiusneularakenne, 
invaasio tavanomaisilla Watson-Crick emäspariutumiseen perustuvilla 
koettimilla on vaikeaa. Yksi tapa parantaa hybridisaatiota on hyödyntää metalli-
ionin välittämää emäspariutumista, ts. oligonukleotidikoettimia, jotka sitovat 
tiukasti metalli-ioneja ja pystyvät muodostamaan koordinoivia sidoksia 
modifioitujen ja luonnollisten nukleoemäksien välillä.	 Tällaiset metallo 
emäsparin sisältävät lyhyet modifioidut oligonukleotidit voivat myös olla 
käyttökelpoisia sellaisten RNA-sekvenssien tunnistamisessa, jotka sisältävät 
hiusneula-rakenteita ja pullistumia, kuten HIV:n TAR sekvenssi. Lisäksi metalli-
ionin sitovat oligonukleotidit voivat olla potentiaalisia sovelluksia DNA-
pohjaisessa nanoteknologiassa. Tässä tutkimuksessa, 3,5-dimetyylipyratsol-1-
yyli substituoitu puriini-johdos liitettiin onnistuneesti oligonukleotidisekvenssiin, 
joko terminaaliseen tai ei-terminaaliseen asemaan.	 Kaikista tutkituista 
modifioiduista oligonukleotideista, 2-(3,5-dimetyylipyratsol-1-yyli)-6-
oksopuriiniemäksen sisältävän oligonukleotidin havaittiin sitoutuvan 
tehokkaimmin modifioimattomaan komplementaariseen sekvenssiin, kun läsnä 
oli joko Cu2+ tai Zn2+ ioni.	 Oligonukleotidi, joka sisälsi 2,6-bis (3,5-
dimetyylipyratsol-1-yyli) puriiniemäksen, lisäsi myös merkittävästi dupleksin 
stabiilisuutta menettämättä selektiivisyyttä Cu2 +:n läsnä ollessa. 
 
Asiasanat: ei-koodaava RNA, microRNA, modifioitu oligonukleotidi, 
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1.1 Structure and biological role of nucleic acids 
Nucleic acids, DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) are 
linear biopolymers that play an important role in encoding, transmitting and 
expressing genetic information for protein synthesis. While DNA appears to 
serve as a relatively passive storage for this information, the biological functions 
of RNA are much more diverse. In particular, the various types of small non-
coding RNA1-7 molecules have recently attracted interest as potential targets for 
diagnostics and chemotherapy.8-22 
Nucleic acid is a polymer that is formed from nucleotides, which consist of a 
pentose sugar, a phosphate group and a nucleobase moiety. The main difference 
between the two types of nucleic acids resides in the structure of the sugar 
moiety: with DNA 2´-deoxyribose and with RNA ribose. The nucleobases are 
either purine (adenine and guanine) or pyrimidine bases (thymine, cytosine and 
uracil). Three nucleobases: adenine, cytosine, and guanine are common to both 
DNA and RNA, whereas thymine occurs in DNA and uracil correspondingly in 
RNA. The nucleobase is connected to C1´ of the pentose sugar through an N-
glycosidic linkage from a nucleobase ring nitrogen: N1 for pyrimidines and N9 
for purines. The nucleosides are, in turn, linked to each other through 3´,5´-











Figure 1. The double-stranded structure of DNA (or RNA) and hydrogen bonding of the 
Watson-Crick base-pairing. DNA: X = H, N = T (R = CH3); RNA: X = OH, N = U (R = 





1.1.1 Watson-Crick base pairing 
The hybridization of DNA into a double helix, as well as the transcription of 
genetic information from DNA to RNA is controlled by Watson-Crick base 
pairing. Adenine recognizes thymine or uracil and guanine recognizes cytosine 
by formation of two and three hydrogen bonds, respectively (Figure 1). Although 
base-stacking plays a more important role in stabilizing the double-helical 
secondary structure,23 Watson-Crick base pairing accounts for the high fidelity of 
the recognition of specific nucleic acid sequences.  
 
1.2 Metal-ion-mediated base pairing 
In metal-ion-mediated base pairing, a specific hydrogen bond is replaced with 
two coordinative covalent bonds. An electronegative atom within the 
nucleobases (or their surrogates) on opposite strands donates an electron pair to a 
common metal ion. This donor atom is usually nitrogen, but it may also be 
oxygen (Scheme 1). While this kind of metal-ion-mediated bonding is weaker 
than real covalent bonds, it still is much stronger than hydrogen bonding, the 
bond energies falling in the range of 10-30 kcal mol-1 and 0.7-1.6 kcal mol-1, 
respectively.23,24 Accordingly, a remarkable duplex stabilization may take place.  
Often the structure of canonical nucleobases has to be modified to achieve 
duplex stabilization by metal ions. Detailed information on the structure of the 
ligands and their ability to bind metal ions is required for the design of workable 
metallo base pairs. It is useful to investigate the structure and stability of the 
metallo base pairs first at monomeric level. This may be carried out by 
crystallography,25 by using DFT (density functional theory) modelling,26-29 or 
NBO (natural bond orbital), MIA (metal ion affinity) and QTAIM (quantum 
theory of atoms in molecules) analysis,30 or by experiments in solution applying 
NMR, EPR (electron paramagnetic resonance) and mass spectrometry and 
UV/Vis spectroscopy.31-34 Many factors, such as acidity, geometry and 

















Scheme 1.  Suggested structure by Lee et al. of a base pair formed by specific hydrogen 
bonds (A:T), and coordination of metal-ion by coordinate covalent bond (A:Zn2+:T);R 
= sugar.35 
 
1.2.1 Lewis and Brønsted Acidity  
The affinity of a given ligand to a given metal ion depends on the Brønsted and 
Lewis basicities of the donor atom(s). Assuming identical steric factors, more 
basic ligands form more stable complexes with metal ions. Hard Lewis acids 
(e.g. alkali metals, alkaline-earth metals, lanthanides) favor hard Lewis bases 
(such as oxygen) and soft Lewis acids (e.g. Ag+, Au+, Cd2+, Hg2+, Pd2+, Pt2+, 
Ru2+) favor soft Lewis bases (such as sulfur and nitrogen). Intermediate metal-
ions (e.g. Mn2+, Fe2+, Co2+, Ni2+, Cu2+ and Zn2+) coordinate reasonably well to 
both hard and soft bases. As a consequence, soft metal ions coordinate to the 
endocyclic nitrogen atoms (N3 of cytosine, thymine and uracil and N1 and N7 of 
guanosine and adenosine) of natural nucleobases (Figure 2).36 In addition, the 
oxo substituents are potential exocyclic ligands that can participate in the 
binding, especially with hard metal-ions. Finally, protons can compete with 
metal ions for binding to a donor atom. For example, guanine N1 and thymine 
N3 (Figure 2 and 3) may only coordinate metal ions in their deprotonated form, 
i.e. under sufficiently basic conditions. Under more acidic conditions, the 
metalation takes place at N7 of guanosine and O4 of thymidine nucleosides 






Figure 2. Purine and pyrimidine structure and their favored coordination sites 
















Figure 3. Acidity constants and protonation/deprotonation features for all natural 
nucleosides (R = sugar).36 
 
 
1.2.2 Geometry and mode of coordination 
Besides the Brønsted and Lewis basicity of nucleobases, steric factors and 
coordination geometry are of importance for metallo base pair formation. For 
example, N1 of adenosine is a poorer ligand for metal ions than N1 of 9-(β-D-
ribofuranosyl)purine even though it is more basic.37 The reason is that the 
exocyclic 6-amino group of adenine causes a steric hindrance for coordination to 
N1. Another important aspect is the geometry of the metal- ion-mediated base 
pairs. The complex should be accommodated within the ideal structure of B-form 
DNA (or A-form RNA). In particular, due to the planar structure of stacked base-
pairs in DNA and RNA, the optimal coordination geometry of a metal ion base 
pair should be planar. Metallo base pairs deviating from the ideal coplanar 


























Figure 4. The perpendicular orientation of a metallo base pair within a double helix 
decreases the π stacking interaction and destabilizes the duplex. 
 
The relative orientation of the nucleobases within a metal-ion-mediated base pair 
is largely dictated by the coordination geometry of the metal ion. In principle, 
linear, trigonal planar (or trigonal bipyramidal) and square-planar (or octahedral) 
geometries can be accommodated within the base-stack of a double helical 
nucleic acid. The metal-ion-mediated base pair can, hence, be formed via 
(1+1)40,41, (2+1)42,43, (2+2)44,45 or (3+1)46,47 types of coordination (Scheme 2A-
F).48,49 Of these, only the (2+2) coordination forces the base pair to assume a co-
planar conformation. The other coordination types allow rotation about one or 
more bonds and especially in the case of sterically demanding ligands, a 
perpendicular conformation may be favored (Schemes 2D-E).39 On the other 
hand, hydrogen bonding interactions between the two ligands may stabilize the 
coplanar conformation (Scheme 2F). Other coordination types such as (3+3), 
(1+1+1) and (2+2+2) have also been reported but they generally lead to 





















Scheme 2. Formation of metallo base pair via (1+1)(A), (2+1)(B), (2+2)(C) and 
(3+1)(D-F) types of coordinaton. Tridentate terpyridine and monodentate imidazole 
(D) and tetrazole with two different binding modes via Pd2+ ion: C1 (E) and N3 (F). R 
= sugar or methyl.39,42,44,51 
 
1.3 Metal-ion-mediated base pairs within unmodified DNA or RNA 
The effect of metal ions on the structure of natural DNA was studied largely in 
the 1960s with a variety of transition metal-ions such as: Co2+, Ni2+, Mn2+, Cd2+, 
Zn2+, Cu2+, Hg2+, Ag+.53,54According to potentiometric, UV-spectrophotometric 
and NMR measurements, only Hg2+ 54 and Ag+ 55,56 were capable of binding 
strongly to nucleobases without unwinding the double helix or binding to the 
phosphate groups. The (1+1) coordination of metal-ion is often observed in this 
case. Divalent metal ions, such as Zn2+, Co2+, and Ni2+, have been reported to 
mediate base pairing at high pH,35 i.e. under conditions where the metal ion is 
able to compete with proton for  N3 of U/T and N1 of G. Metal-ion-mediated 
base-pairing has been reported for both Watson-Crick pairs as well as C:C and 
T:T (or U:U) mispairs.57-61 The term metal-DNA was first used by Lee et al.49,62 
The best-known example of metal ion coordination to unmodified nucleic acids 
undoubtedly is the crosslinking of DNA by platinum compounds.63 However, as 
these compounds tend to distort the DNA double helix rather than form well-
defined metallo base pairs within it, they fall beyond the scope of this 
dissertation. 
Incorporation of metal ions within canonical Watson-Crick base pairs at high pH 
has been demonstrated with divalent Zn2+, Co2+, and Ni2+ ions by Lee et al.35,64 
The metal ion coordination was studied by NMR titration by tracking the proton 






of the protons, either N3-H of thymine or N1-H of guanine, was replaced by a 
divalent metal-ion and thus, one positive charge was left on the double helix. 
Alternative modes for incorporation of metal ions to natural base pairs has been 
suggested by Lippert et al. (Figure 5B)65 and Alexandre et al. (Figure 5C).66   
 
 
Figure 5. Suggested structures of the natural base pairs in the presence of Zn2+ion 
according to Lee´s (A), Lippert´s (B) and Alexandre´s (C) model (R = sugar).35,62,65,66 
 
The most extensively studied example of a mispair stabilized by a bridging metal 
ion is the T:Hg+:T base pair (Figure 6), first suggested by Katz as early as 
1963.49,57 The formation of T:Hg+:T metallo base pairs has since been confirmed 
by X-ray crystallography.58,67 Further studies on the coordination of the Hg2+ to 
two thymines were carried out by Ono et al. using fluorescence, melting 
temperature and ESI mass spectrometric measurements.68-70 The DNA structure 
was also explored by NMR, using 15N3-labeled thymine bases, which allowed 
the measurement of the 2JNN coupling constant.33,70 By this method, formation of 







Figure 6. Suggested model of Katz for formation of metallo base pair T:Hg:T by 





Figure 7. Suggested model for C:Ag:C base pair with either trans or cis 
conformations.71 
 
A C:C mispair may also be stabilized by metal ion coordination, but in this case 
Ag+, rather than Hg+, is the preferred metal ion.60,61 This mismatched metallo 
base pair occurred  either in trans (parallel duplex) or cis (antiparallel duplex) 
conformation (Figure 7).71 The 8-mer DNA oligonucleotide (ON), which 
contained cytosine bases only, was by CD and UV spectroscopy shown to form 
C:Ag+:C base pairs with a parallel orientation of the strands.31  
RNA has not been explored as much as DNA, most likely because RNA is more 
susceptible to enzymatic degradation. The first report on a metal-ion-mediated 
RNA base pair was an Au3+-mediated  G:C-base pair, formed by accident during 
crystallization.72  
The Müller group incorporated a metal-mediated base pair, U:Hg2+:U within a 
double-stranded oligoribonucleotide (ORN).59 The study was carried out with 
five different RNA structures (Table 1).59 Some of these ORNs were non-






residues in the middle of the sequence (ON1 and ON2) and the rest were partly 
palindromic (ON3-ON5) containing oligo(U) loops of different lengths. The Tm 
increased in nearly all cases upon addition of Hg2+. The stabilization correlating 
with the number of uracil bases. The stabilization of non-palindromic duplexes 
ON1 and ON2 results from conversion of U:U-pairs to U:Hg2+:U –pairs, while 
the palindromic ON3-ON5 undergo transition from unimolecular hairpin to 
bimolecular duplex upon formation of the metallo base pairs. To verify this, 
diffusion-ordered NMR spectroscopy (DOSY NMR) and dynamic light 
scattering (DLS) methods were used to determine the size of ORN structures in 
the presence of Hg2+.34 Hydrodynamic radii (rH) were measured to distinguish 
between hairpin and metal-ion-mediated duplex structures (Table 1). After 
addition of Hg2+ ion, ON3 experienced an increase in the value of rH by 
approximately 30% (Scheme 3), while the ON1 and ON2 remained unaffected. 
The results obtained with ON4 and ON5 were less clear, suggesting that these 






Scheme 3. Increasing of hydrodynamic radii (rH) from hairpin structure to double helix 















Table 1. Hydrodynamic radii rH of ON1-ON5 as determined by DLS(rH,DLS) and 
DOSY NMR (rH,DOSY) before and after addition of 1.2 equiv. of Hg2+. In case the 






















































































ON3 evidently underwent conversion from hairpin into an A-type homoduplex 
through metal-ion-mediated base pairs. This conformational change was further 
verified by 1H, 1H NOESY and 1JHC-HSQC spectrometric measurements with 
15N and 13C-enriched compounds, and by CD spectroscopy.59,73,74 Lengthy 
treatment of the metallated ORNs, ON1-5, with a chelating Chelex resin 
removed Hg2+ from the U:Hg2+:U base pairs.59 The same treatment did not, 
however, removed Hg2+ from the T:Hg2+:T base pair within corresponding DNA 
duplexes.33 It was presumed that the base pairs and, hence, the bridging metal 
ions, are more exposed to solvent in A-type RNA than in B-DNA structure.  
 
1.4 Metal-ion-mediated base pairs within modified DNA or RNA 
Numerous modified nucleosides capable of forming metal-ion-mediated base 
pairs, both homo- and heterodimers, have been described.26,46,47,49 The potential 
application area has been anticipated to cover several interesting fields such as: 
DNAzymes, molecular mechanism of gene mutations related to heavy metal-
ions, and creation of molecular nanodevices and medical materials. The diversity 
of transition metal ions used to bridge the modified nucleobases is almost as 







1.4.1 Metal-ion-mediated base pairs with (1+1) coordination 
In addition to the T:T, U:U and C:C mispairs described above, several artificial 
monodentate ligands form Ag+- or Hg2+-mediated homo-base pairs through linear 
coordination to the central metal ion.40,41,75,76 The base pair adopts a coplanar 
geometry within a double helix (see section 1.2.3)75 and  maintains	 a B-
conformation of the DNA duplex, providing that there is no marked steric 
repulsion between the modified bases.41,77 As an example, three 1,2,4-triazole 
nucleosides were incorporated next to each other within the loop of a hairpin ON 
(Scheme 4A).40 Formation of the hairpin structure in the absence of Ag+ ion was 
verified by independence of the Tm value of the oligonucleotide on its 
concentration, as well as by FRET experiments. When 3 equiv. of Ag+ were 
added, the hairpin structure was transformed to a double helix by formation of 
three consecutive triazole:Ag+:triazole base pairs, as evidenced by conversion of 
the Tm value to concentration-dependent. Formation of the Ag+-mediated homo-
duplex was additionally verified by FRET, MS and DLS experiments. Addition 
of Hg2+, on the other hand, destabilized the double helix by 2 °C per equiv. of 
Hg2+.40 The destabilization was suggested to result from either the ability of Hg2+ 




Scheme 4. Formation of metal-ion-mediated base pairs through either triazole (A) or 
imidazole (B) nucleobase and simultaneous change of ON from hairpin structure to a 






Similar results were obtained with imidazole nucleosides (Scheme 4B).78 
Incorporation of a methyl group vicinal to the donor nitrogen (position 2 or 4 of 
the imidazole ligand) was also tolerated (Figure 8A) and, in fact, led to a larger 
increase in Tm upon addition of Ag+ (ON6, Table 2).41 Finally, two 3-pyridine 
nucleosides form a similar Ag+-mediated homo-base pair that was slightly 




Figure 8. Ag+-mediated pairs between two unidentate surrogate bases.41,51 
 
 
Table 2. The effect of various metallo base pairs with (1+1) coordination on the 
stability of double helices of complementary oligonucleotides. 
 a 3 equiv. of Ag+ ion. b 2 equiv. of Ag+ ion. c pH is 7.4 or 9.0. d pH is 6.0 
 
The linear coordination geometry of Ag+ allows formation of more than one Ag+ 
bridges between appropriate ligands. As could be expected, such dinuclear 
metallo base pairs can be highly stable. For example, a single thiopyrimidine 
homo-base pair with two Ag+ ions (Figure 9A) increased the Tm of a double-
helical DNA oligonucleotide (ON8) by 23 °C relative to the metal-free duplex.79  
 Sequences Modified base pair (X) 
with metal ion 
Tm Ref. 




















3´-dCT CCCT XTCT TTC 



























Recently 1,N6-ethenoadenine (A) was explored as a Ag+-mediated base pair in a 
DNA system.76 Two Ag+ ions could bind by (1+1) coordination to the N6 and N7 
atoms of this base (Figure 9B) and the duplex (ON9) was considerably stabilized 
(Tm = +12 °C). Similar two silver ion systems exhibiting even greater 
stabilization have been constructed by using either methyl- (mePyr-dC) or phenyl-
substituted pyrrolocytosine (phIm-dC and phPyr-dC) as the artificial nucleobase 
(Figure 9C).32,80 The best example  is phIm-dC:phIm-dC base pair which stabilize 
the DNA duplex (ON10) by +38.5 °C upon addition of 2 equiv. Ag+ under 
neutral and basic conditions. The duplex ON10 is also markedly stabilized by 
metallo base pair phPyr-dC:(Ag+)2:phPyrdC (Table 2) under the same conditions. 
When conditions are changed to slightly acidic, the phIm-dC:(Ag+)2:phImdC base 
pair still retains the high stability (Tm = +30 °C), but with 
phPyrdC:(Ag+)2:phPyrdC only very modest change was observed (Tm = +2.5 °C). 
Apparently N9 is deprotonated much more easier in phIm-dC compared to N7 
deprotonation of phPyrdC. One phPyr-dC:(Ag+)2:phPyr-dC base pair stabilized the 
double helix (ON10) more than one mePyr-dC:(Ag+)2:mePyr-dC base pair. 
However, the situation was reversed, when two sequential metallo base-pairs 
were incorporated in the middle of ON11 (Table 2). Interestingly, both modified 
phIm-dC and phPyr-dC bases were paired with G in the middle of duplex ON10 
and stabilized the helix in the absence of metal ion more than the natural Watson-
crick base pair (C:G). But the effect of Ag+ ion is negligible. The phIm-dC:C and 
phPyr-dC:C base pairs were not as stable as with G in the absence of metal ion, 
but show some stability of duplex after addition of Ag+ (Tm = 10.5 °C and +3.5 

















Figure 9. Metallo base pairs with (1+1) coordination of two metal-ions.32,76,79 
 
 
1.4.2 Metal-ion-mediated base pairs with (2+1) coordination 
Ag+ also forms trigonal-planar complexes but these have been less widely 
exploited in studies on metal-ion-mediated base pairing. Only very recently, the 
first artificial metallo base pair with (2+1) coordination was introduced. This 
Ag+-mediated base pair was formed between 4-[(1H-1,2,4-triazol-1-yl)methyl]-
1H-1,2,3-triazole (TriTri), containing two triazole rings, and imidazole (Figure 
10A).42 None of the other metal ions (Au3+, Cu2+, Co3+, Cr3+, Fe2+, Hg2+, Mn2+, 
Ni2+ and Zn2+) screened offered comparable stabilization. Furthermore, when 
imidazole in the middle of duplex ON12 was replaced with either cytosine or 
thymine, the stabilizing effect of Ag+ was much more modest (Table 3), but 
addition of Ni2+ then reasonably stabilized the double helix. Analogous structures 
featuring pyrazole (TriPyr, Figure 10B) or pyridine (TriPy, Figure 10C) in place 
of the 1,2,3-triazole ring were also tested.43 When incorporated within a 13-mer 
double-stranded oligonucleotide (ON13), the highest stabilization was achieved 












Figure 10. Metallo base pairs with (2+1) coordination of metal-ion.42,43 
 
Table 3. The effect of various metallo base pairs with (2+1) and (2+2) coordination on 
the stability of double helices of complementary oligonucleotides. 







X:X X:Y  
ON12 5´-dGAGGGAXAGAAAG/ 
3´-dCT CCC TYT CT TTC 
TriTri* Im +2.1a,f +0.1b/+6.0c 42 
43 
ON13 5´-dAGAAAGXGAGGGA/ 
3´-dTC T TT CYCT CCCT 
TriPy Im +1.4a +12.6a 43 
ON13 5´-dAGAAAGXGAGGGA/ 
3´-dTC TT TC YCT CCCT 
TriPyr TriPy +2.8a +7.4a 43 
ON14 5´-dCACATTAXTGTTGTA/ 
3´-dGTGTAATXACAACAT 





     - +7.5 - 89 
ON16 5´-dCTTT CTX TCCCT/ 
3´-dGAAAGAXAGGGA 
PurP      - +17.6c/+2.9b - 90 
ON16 5´-dCTTT CTX TCCCT/ 
3´-dGAAAGAXAGGGA 
PyrP      - +16.5c/+2.1b - 45 
ON14 5´-dCACATTAXTGTTGTA/ 
3´-dGTGTAATXACAACAT 
PurC      - +8.3c/+22.7b - 91 
ON14 5´-dCACATTAXTGTTGTA/ 
3´-dGTGTAATXACAACAT 
Salen      -   +13.8d/+41.3e - 93 
 awith Ag+; bwith Cu2+; cwith Ni2+; d1.3 equiv. of Cu2+.eAddition of 100 µM 
ethylenediamine with 1 equiv. Cu2+; fThe sequence is the same as with 
TriPyr.*Additionally, TriTri:C bases with Cu2+ (+0.6) or Ag+ (+1.4), TriTri:T bases with 





1.4.3 Metal-ion-mediated base pair with (2+2) coordination 
Most artificial metal-ion-mediated base pairs described in the literature are based 
on (2+2) coordination.48,49 In the case of metal ions with square-planar 
coordination environment, this coordination type forces the base pair to adopt a 
coplanar conformation even at the monomer level. The most widely utilized 
among such metal ions are Cu2+, Ni2+, Pd2+ and Pt2+.48 The first example of a 
modified nucleoside engaged in metal-ion-mediated base pair with (2+2) 
coordination was published by Tanaka and Shionoya in 1999 (Figure 11A).81 
Initially, an O-phenylenediamine complex with Pd2+ was synthesized, followed 
by similar derivatives with Cu2+ and B3+.81-84 These artificial metallo base pairs 
were only studied at the monomer level. The isosteric Cu2+-mediated 3-
hydroxypyridin-4-one (H) homo-base pair (Figure 11B) was, in turn, embedded 
into a number of different ON duplexes.44,85 As many as five consecutive metallo 
base pairs could be accommodated within a single 7-mer ON, as confirmed by 
UV and CD titrations and EPR and mass spectrometry.85  According to the EPR 
data, the Cu2+ ions were ferromagnetically coupled on top of each other, with a 
distance of 3.7 Å (the respective value for unmodified B-type DNA is 3.3-3.4 Å). 
When the 3-position of 2-pyridone was substituted by sulfur, soft metal ions such 
as Pd2+, Pt2+ or Ni2+ formed stable base pairs at monomeric level.86  
Additionally, derivatives of 2,2´-bipyridine (BPy), where the base was attached 
either directly or via a methylene group to the anomeric carbon, have been 
studied.87-89 The  BPy:BPy pair significantly stabilized a 19-mer DNA duplex in 
the absence of metal ion,87 but addition of metal ions resulted in destabilization 
(Figure 11C).88 By contrast,  5-methyl-2,2´-bipyridine stabilized a 11-mer DNA 
helix (ON15, Table 3) by 7.5 °C upon addition of Cu2+ ion (Figure 11D).89 The 
related pyridyl-substituted derivatives (PurP and PyrP) of the natural nucleobases 
adenine and cytidine (Figure 11, E and F) markedly enhanced hybridization of 
ON16 duplex through Ni2+-mediated homo-base pairing (Table 3).45,90 This 
effect was not observed with the other divalent metal ions screened (Co2+, Cu2+, 

















Figure 11. Metallo base pairs with (2+2) coordination of metal-ion. 43-45,81,87-91 
 
Finally, this type of coordination has been recently studied with 
TriPyr:Ag+:TriPy (Figure 11G) and PurC:Cu2+:PurC (PurC = 6-carboxypurine) 
(Figure 11H) base pairs.43,91 The TriPyr:Ag+:TriPy metallo base pair reasonably 
stabilized ON13 duplex (Table 3), but none of the other metal ions screened 
(Hg2+, Cu2+, Zn2+ and Ni2+) had any significant stabilizing effect.43 By contrast, 
PurC:PurC base pair that was markedly stabilized by Cu2+ (ΔTm = 22.7 oC for a 9-
mer DNA duplex ON14, Table 3)  was moderately stabilized also by other metal 
ions, such as Ni2+, Zn2+, Co2+, Fe2+, Fe3+, Hg2+ and Mg2+ (Tm = +5-8 °C). In this 




An innovative and unusual type of metal-ion-mediated base pair based on (2+2) 
coordination of Cu2+ to two nucleosides derived from salicylaldehyde was 
presented by the Carell laboratory.92 Two of these modified nucleosides were 
placed opposite to each other in the middle of a 15-mer double-helical DNA ON. 
The duplex with a melting point of 41.1 °C, exhibited ΔTm of +13.8 upon 
addition of Cu2+ ion. This stabilization by  Cu2+ is comparable to the effect of the 
H:Cu2+:H base pair within the same double-stranded DNA (ON14), examined by 
Tanaka et al (ΔTm = 13 °C).44 The stability of the Cu2+:salicylaldehyde base pair 
was vastly increased when ethylenediamine was added (Tm = +41.3 °C, Table 
3).93 The salicylic aldehyde can condense with	ethylenediamine linker producing 




Figure 12. The metal–salen base pair.92 
 
The salen cross-link in the presence of a metal ion, such as Cu2+, increases the 
melting temperature immensely, from 45.5 to 82.4°C.93 In the presence of only 
ethylenediamine (Tm = 45.5 °C) or just Cu2+ ion (Tm = 54.9 °C) the stabilization is 
more modest. The other metal-ions explored included Mn2+, VO2+, Fe3+, and 
Ni2+. Mn2+, which oxidized to Mn3+ under aerobic conditions, exhibited a higher 
melting temperature of 68.8 °C (Table 3).92,93  
As a demonstration of the compatibility of the metallo-salen base pair formation 
with DNA hybridization, ten of these base pairs were incorporated within a 
double-helical DNA ON and either Mn3+ or Cu2+ was used as the bridging metal 
ion. Formation of the desired assemblies was confirmed by ESI-ICR mass 
spectrometry (in the presence of Mn3+)	or UV spectrophotometric titration (in the 
prescence of Cu2+).94 
The capacity of stacking between ten adjacent artificial metallo base pairs within 
the DNA was studied with different metal ions. To this end, two orthogonal 
ligands (hydroxypyridone and pyridine) for two different metal ions (Cu2+ and 
Hg2+, respectively) were incorporated into the same DNA ON.44,49,85,95,96 In 






base pairs were incorporated next to each other within a DNA oligomer (Figure 
13). Coordination of the desired metal ions with correct stoichiometry to the 




Figure 13. DNA incorporating several adjacent or alternating Cu2+-salen and 
thymine:Hg2+:thymine base pairs.48,95 
 
1.4.4 Metal-ion-mediated base pair with (3+1) coordination 
Square-planar geometry around the bridging metal ion can also be achieved 
through (3+1) coordination, giving rise to metal-ion-mediated hetero-base pairs. 
In this approach, the metal ion is bound much more strongly by the tridentate 
than by the monodentate ligand. The first artificial base pair embedded into an 
ON duplex exploiting this asymmetrical coordination mode was 3-pyridine:2,6-
pyridinedicarboxylate (Dipic) (Figure 14A).46,97 In this case, Dipic formed a 
planar tridentate chelate with the metal ion, such as: Cu2+, Ag+, Ni2+, Pd2+, and 
Pt2+, the monodentate ligand occupying the fourth coordination site. The most 
stable duplex (ON14) was obtained with Dipic:3Py base pair in the presence of 
Cu2+ (Table 4), whereas other metal ions, such as Ce3+, Mn2+, Fe2+, Co2+, Ni2+, 
Zn2+, Pd2+ and Pt2+, did not have any significant affect. Even greater stabilization 
was observed with the nitrogen analog (Dipam, Table 4) pyridine-2,6-




any effect on stabilization compared with Dipam and Dipic. When the Dipic and 
Dipam bases were situated opposite to natural bases, the Tm values ranged from 
25.5 to 34.5°C. The most stable mispairs after addition of Cu2+ were Dipic:dA 





Figure 14. Metallo base pairs with (3+1) coordination of metal ions.46,47,98-100 
 
Schultz et al. succeeded in obtaining the first crystal structure of a self-
complementary double-stranded DNA oligonucleotide incorporating two 
artificial dipic:Cu2+:3Py metallo base pairs (5´-CGCGDipicATPyCGCG-3´).48,97 
This CG-rich palindromic ON crystallized in the unusual Z-conformation. In this 
Z-type ON, the metallo base pairs have square planar structure and the Cu2+ ion 






nucleosides (the furanose oxygen and guanine-O6), resulting in an octahedral 
coordination geometry.97,101   
Another family of modified nucleobases exploiting (3+1) coordination consists 
of terpyridine (Scheme 2) and its analogs (Figure 14B-E), Bipyridylpyrimidinone 
base, for example, forms with 4-pyridine (Figure 14B) a stable Ag+-mediated 
base pair within double-stranded ON16 (PyrBipy:Ag+:4Py).99 A 12.9 °C increase 
in Tm was observed on addition of Ag+ (Table 4), whereas none of the other metal 
ions studied (Mn2+, Mg2+, Cu2+, Fe2+, Co2+, Ni2+, Zn2+ and Tl+) showed any 
significant stabilization.99 Attachment of either one bipyridyl or two pyridyl rings 
to purine also affords terpyridine analogs (Pur6-Bipy and Pur2,6-Py) and the impact 
of Ag+ ion has been explored with these modified nucleobases.47 The 
monodentate ligand in these studies was either a natural (A, G, C and T) or 
another modified (3-Py, 4-Py,) nucleobase. Only the metallo base pairs Pur6-
bipy:Ag+:4Py (Figure 14C) and Pur2,6-Py:Ag+:3Py (Figure 14D) stabilized duplex 
ON16 compared to the Watson-Crick base paired counterpart (C:G, Tm = 38.0 
°C).47 6-(1H-1,2,3-Triazole-4-yl)-2,2´-bipyridine offers yet another example of a 
terpyridine-type ligand.100 A Ag+-mediated base pair between this ligand and 
imidazole (Figure 14E) was moderately stabilizing: the melting temperature of a 
double-stranded ON12 placing these modified nucleosides opposite to each other 
was increased by approximately 5 °C on addition of Ag+.  
 
Table 4. The effect of various metallo base pairs with (3+1) coordination on the 
stability of double helices of complementary oligonucleotides  
Mod. base Metal 
ion 
Tm Ref. 
X Y X:X X:Y X:A X:C X:G X:T  
Dipic 3-Py Cu2+ - 10.0 -2.4a -10.5a -7.9a - 46 
Dipam 3-Py Cu2+ - +15.0 -13.0a -17.5a -8.5a -15.5a 98 
PyrBipy 4-Py Ag+ -1.1 +12.9 +5.0 +3.5 +5.4 +2.5 99 
Pur6-Bipy 4-Py Ag+ +6.7 +11.1 +3.3 +1.1 +5.5 +1.7 47 
Pur2,6Py 3-Py Ag+ +12.0 +16.5 +3.5 +3.8 +12.0 -5.0 47 
 aComparison with Dipic:Cu2+:3Py metallo mispairs.  
 
1.5. Metal-ion-mediated base-pairing between modified and natural 
nucleic acids 
The first reported metal-ion-mediated base pair between a modified and a natural 
nucleobase was the Ag+-mediated pair between 1-deazaadenine and thymine 




nonetheless it closely resembles adenine. Actually 1-deazaadenine and thymine 
form a Hoogsteen base pair due to the absence of N1 of 1-deazaadenine.104 When 
this base pair was incorporated into ON17 [d(ADADADADA):d(T9)] and ON18 
[d(D19A):d(T20)] duplexes, the Tm increased from 10 °C in the absence of metal 
ions Ag+ to 51.2 °C in the presence of 1 equiv. of Ag+.26 The structure of the 
duplex was elucidated by CD and UV spectroscopy.104 The stability of D:Ag+:T 




Scheme 5. 1-Deazaadenine:thymine base pair in the absence and presence of Ag+.26,104 
 
Likewise, 1,3-dideaza-6-nitropurine (I) has been used as a modified nucleobase, 
that forms a Ag+-bridged complex with cytosine (Scheme 6).31 According to CD 
spectra, this base pair is not formed and the increase in Tm of self-complementary 






Scheme 6. Suggested structure of Hoogsteen arrangement of cytosine:1,3-dideaza-6-







The data on recognition of natural ONs with probes incorporating metal-ion-
binding surrogate bases still is limited leaving space for additional studies. The 
study discussed in the following hopefully is one step on the way to high-
affinity-binding probes that still retains sequence selectivity. 
Aims of the Thesis 
 
34 
2. AIMS OF THE THESIS 
MicroRNAs (miRNA) are small non-coding RNAs that have a hairpin structure 
and usually one or more bulges within the double helical stem.105 They play, after 
being processed by the Dicer enzyme, a role in regulation of gene expression, but 
they are additionally excreted in hairpin form into blood circulation.106,107 Owing 
to the fact that the spectrum of miRNAs turns abnormal in severe diseases, such 
as cancer, they constitute an emerging target for diagnostics and in all likelihood 
also for chemotherapy.108-111 One of the problems encountered is that traditional 
oligonucleotide probes are not able to recognize miRNA by chain invasion, 
owing to the stable hairpin structure of miRNA. This study is aimed at 
developing modified oligonucleotides that through metal-ion-mediated base 
pairing show enhanced and preferably selective affinity to their natural 
counterparts. Such probes expectedly are useful for recognition of miRNAs and 
related hairpin-like structural motives of RNA, such as the TAR sequence of 
HIV.112-115 
To achieve this general goal 
(i) Analogs of purine bases that bind tightly soft and 3d transition metal ions are 
synthesized and converted to building blocks compatible with solid phase ON 
synthesis by the phosphoramidite chemistry. 
(ii) The metal-ion-binding surrogate nucleosides are incorporated into terminal 
and non-terminal positions of oligonucleotides and their influence on the duplex 
stability in the absence and presence of metal ions is studies by UV- and CD-
based duplex melting studies. The aim is to learn more about the structural 
factors that allow in the presence of metal ions high stability and good 
selectivity. 
(iii) The applicability of such metal-ion-binding oligonucleotides as probes with 







3.1 Synthesis of modified nucleosides and their conversion to 
phosphoramidite building blocks    
3.1.1 Phosphoramidite building blocks derived from 2,6-bis(3,5-
dimethylpyrazol-1-yl)-9-(β-D-ribofuranosyl)purine (1) and 2-(3,5-
dimethylpyrazol-1-yl)inosine (4) 
2,6-Bis(3,5-dimethylpyrazol-1-yl)-9-(β-D-ribofuranosyl)purine (1) was prepared 
by treating commercial 2´,3´,5´-tri-O-acetyl-6-chloro-2-iodo-9-(β-D-
ribofuranosyl)purine (2) with hydrazine hydrate at room temperature to obtain 
deacetylated 2,6-dihydrazinyl-9-(β-D-ribofuranosyl)purine (3) (Scheme 7).116 
Treatment of 3 with pentane-2,4-dione then gave 1.117  
2-(3,5-Dimethylpyrazol-1-yl)inosine (4) was prepared from 1 by nucleophilic 
displacement of the 6-(3,5-dimethylpyrazol-1-yl) substituent with ammonia 
(giving 5) and subsequent oxidative removal of the 6-amino group with sodium 
nitrite in aq. acetic acid, giving 4. 
Nucleosides 1 and 4 were finally converted to 3´-(2-cyanoethyl-N,N-
diisopropylphosphoramidite) building blocks compatible with the conventional 
oligonucleotide synthesis by the phosphoramidite strategy. Accordingly, the 5´-
OH of 1 and 4 was protected as a 4,4´-dimethoxytrityl ether, the 2´-OH was 
silylated with tert-butyldimethylsilyl chloride and the 3´-OH was phosphitylated 
with 1-chloro-1-(2-cyanoethoxy)-N,N-diisopropylphosphanamine by using 
conventional methods. The experimental details and characterization of the 

































Scheme 7. Preparation of 2,6-bis(3,5-dimethylpyrazol-1-yl)-9-(β-D-
ribofuranosyl)purine (1) and 2-(3,5-dimethylpyrazol-1-yl)inosine (4) and their 
conversion to phosphoramidite building blocks. Reagents and conditions: (a) 
H2NNH2H2O; (b) pentane-2,4-dione, TFA; (c) DMTrCl, pyridine; (d) TBDMSCl, 
imidazole, DMF; (e) 1-chloro-1-(2-cyanoethoxy)-N,N-diisopropylphosphanamine, Et3N, 
CH2Cl2; (f) NH3, aq. (g) NaNO2,aq., AcOH.118,119 
 
 
3.1.2 Phosphoramidite building block derived from 6-(3,5-
dimethylpyrazol-1-yl)-9-(-D-ribofuranosyl)purine (11) 
6-(3,5-Dimethylpyrazol-1-yl)-9-(β-D-ribofuranosyl)purine (9) was synthesized 
by first displacing the chloro substituent of 6-chloro-9-(β-D-ribofuranosyl)purine 
(10) with hydrazine and then converting the hydrazinyl substituent to a 3,5-
dimethylpyrazol-1-yl group by reacting with pentane-2,4-dione (Scheme 8).117 
The 5´-OH of 9 was then protected as a 4,4´-dimethoxytrityl ether and the 2´-OH 
was silylated with TBDMSCl. Finally the 3´-OH was phosphitylated as above to 
yield the phosphoramidite building block 10.119 The experimental details are 

















































Scheme 8. Preparation of 6-(3,5-dimethylpyrazol-1-yl)-9-(-D-ribofuranosyl)purine 
and its conversion to a phosphoramidite building block. Reagents and conditions: (a) 
H2NNH2H2O; (b) pentane-2,4-dione, TFA; (c) DMTrCl, pyridine; (d) TBDMSCl, 





3.1.3 Phosphoramidite building block derived from of 2,6-bis(1-
methylhydrazinyl)-9-(β-D-ribofuranosyl)purine (13) 
2,6-Bis(1-methylhydrazinyl) )-9-(β-D-ribofuranosyl)purine (12) was synthesized 
by treating 2´,3´,5´-tri-O-acetyl-6-chloro-2-iodo-9-(β-D-ribofuranosyl)purine (2) 
with N-methyl- hydrazine at room temperature,117 as described above for the 
reaction with hydrazine. The 1-methylhydrazinyl groups were protected as 
trifluoroacetamides using ethyl trifluoroacetate as the acylating agent (Scheme 
9). The nucleoside obtained (14) was converted to the 3´-phosphoramidite 
building block (13) as described above for 6 and 7. The experimental details are 







Scheme 9. Preparation of 2,6-bis(1-methylhydrazinyl)-9-(β-D-ribofuranosyl)purine and 
its conversion to a phosphoramidite building block. Reagents and conditions: (a) 
MeNH2NH2; (b) ethyl trifluoroacetate, Et3N, MeOH; (c) DMTrCl, pyridine; (d) 
TBDMSCl, imidazole, DMF; (e) 1-chloro-1-(2-cyanoethoxy)-N,N-




3.2 Synthesis of 9-[3´-O-tert-butyldimethylsilyl-5´-O-(4,4´-
dimethoxytrityl)-2´-O-succinoyl-β-D-ribofuranosyl]-2,6-bis (3,5-dimet- 
hylpyrazol-1-yl)purine (16) and its immobilization to a solid support 
9-[3´-O-tert-Butyldimethylsilyl-5´-O-(4,4´-dimethoxytrityl)-β-D-ribofuranosyl]-
2,6-bis(3,5-dimethylpyrazol-1-yl)purine (15), obtained as a side product of the 
synthesis of 8, was 2´-O-succinylated with succinic anhydride (Scheme 10). A 
lengthy 8 d treatment at 40 to 50 °C was required for complete (97%) the 
conversion of 15 to 16.120  
Compound 16 was immobilized to a long chain aminoalkyl-CPG by conventional 
HBTU-promoted peptide coupling. The loading of the functionalized CPG was 










Scheme 10. Immobilization of 9-[3´-O-tert-butyldimethylsilyl-5´-O-(4,4´-
dimethoxytrityl)-β-D-ribofuranosyl]-2,6-bis(3,5-dimethylpyrazol-1-yl)purine (15) to a 
solid support. Reagents and conditions: a) succinic anhydride, pyridine (dry); b) long 
chain aminoalkyl-CPG, HBTU, DIPEA.120 
 
3.3 Synthesis of oligonucleotides  
3.3.1 Synthesis of unmodified oligonucleotides  
The unmodified 2´-O-methyl ORNs listed in Tables 5-7 were synthesized from 
commercial 2´-O-methylated RNA phosphoramidite building blocks on an 
automated RNA/DNA synthesizer. The coupling yields were always > 98 % by 
the DMTr response. After chain assembly, all ORNs were deprotected and 
released from the support by standard ammonolysis (33% aq. NH3, 55 °C, 5 h). 
The crude ORNs then were purified by RP-HPLC and their identity was 
characterized by electrospray ionization mass spectrometry (ESI-MS).  
 
3.3.2 Synthesis of modified oligonucleotides  
The non-terminally modified 9-mers 2´-O-Me-ORN, ON1i (I = X, Q, P, Y) 
(Table 5) incorporating an artificial nucleoside (1, 4, 9 or 14, respectively) in the 
middle of the strand were synthesized from commercial 2´-O-methylated 
protected phosphoramidite building blocks on an automated synthesizer with the 
exception of insertion of the modified building block that was coupled manually 
using a long coupling time (60 min). The coupling yields for the modified 
building blocks 1, 4, 9 and 14 were 36, 41, 40 and 44%, respectively, while the 
other couplings proceeded with normal efficiency (approximately 99%). In the 
case of ON1Y, the 1-methyl-2-(trifluoroacetyl)hydrazinyl groups of the modified 
nucleoside 14 were converted to 2-acetyl-1-methylhydrazinyl groups during the 




the final ammonolysis removed only the more labile trifluoroacetyl protections 
(Scheme 11). The 9-mer oligonucleotide ON1Z, containing 2-(3,5-
dimethylpyrazol-1-yl)adenosine (5) in a non-terminal position, was prepared 
from oligonucleotide ON1X in approximately 40% yield by an extended 
treatment with 33% aq. NH3 (6 h at 55 °C). Under these conditions, the 
dimethylpyrazol-1-yl substituents on C6 was displaced by ammonia. The other 
ONs (ON1i, i = P, Q, Y) were released from the support and the phosphate and 
base protections were removed by conventional treatment with ammonia (33% 
aq. NH3, 55 °C, 4-5 h).119,120 
To estabilish the site of displacement of the dimethylpyrazol-1-yl group within 
the purine base, a sample of the modified nucleoside (1) was kept under the 
deprotection conditions, i.e. in concentrated aq. ammonia (33%) at 55 °C for 5 h. 
The product mixture formed was then examined by 1H NMR and HMBC which 
verified that 50% of 1 had been converted to essentially one product. On the 
basis of HMBC, this was 2-(3,5-dimethylpyrazol-1-yl)adenosine (5). The product 
(5) clearly indicated coupling of the C5 atom of the purine ring to the hydrogen 
atoms of an exocyclic amino group (Figure 15B). This correlation is not 
observed before ammonolysis (Figure 15A). In all likelihood ammonia had 
displaced the 3,5-dimethylpyrazol-yl group at a carbon neighboring C5, i.e. at C6 
(Scheme 12). This reaction seems to occur more readily at the 3´-terminal site 




































































In addition, a modified oligonucleotide, ON2S, having an abasic site opposite to 
the modified nucleoside in ON1i (i = X, Z, P, Q) was prepared. The abasic site 
was created with a commercial 2-(hydroxymethyl)tetrahydrofuran-3-ol block  
(see Table 5). 
The modified 6-, 5- and 4-mer 2´-O-Me-ORN (ON4Xi and ON5Xi, where i = U, 
A, G, C; ON5Xa, ON5Xb, ON6X, ON7X, ON8X, ON9X and ON10X) bearing 
the artificial nucleoside 1 at the 3´-terminus were synthesized on the solid 
support obtained by immobilization of nucleoside 16b, as discussed above 
(Scheme 10). The ORNs were assembled on an automated synthesizer, the 
couplings proceeding with normal efficiency (approximately 99%). As described 
above for the synthesis of ON1Z, the dimethylpyrazolyl group at position 6 of 
the modified nucleoside 1 was displaced by ammonia during the ammonolysis 
(33% aq. NH3, 55 °C, 5 h), affording ONs ON4Zi (i = U, A, G, C). According to 
HPLC, 37% of ON4Xi oligonucleotides were coverted to their ON4Zi 
counterparts. Oligonucleotides containing an intact modified nucleoside X were 









Figure 15. HMBC spectra of 
the modified nucleoside 1 (A) 
before and (B) after 5 h 
incubation in concentrated 
aq. ammonia at 55 °C. 
Before ammonolysis, only 
coupling of C5 to H8 is 
detected. After ammonolysis, 
coupling of C5 to NH2 is 
additionally seen. The 





For all modified ONs, the TBDMS group was removed with 1.53 M 
triethylamine trihydrofluoride in dry DMSO (2 h at 55 °C). The crude products 
were purified by RP-HPLC and their identity and purity verified by ESI-MS 
analysis. The concentrations of the purified products were determined UV-
spectrophotometrically at λ= 260 nm using molar extinction coefficients 
calculated by an implementation of the nearest-neighbors method.121-123 
 
Table 5. Structures and m/z valuesa of the unmodified and non-terminally modified 9-
mer 2´-O-Me-ORNs used in the present study. 
 Sequence m/z (obsd.) m/z (calcd.) 
ON1X 5´-GCGCXCCGG-3´ 3152.8 3152.7 
ON1Y 5´-GCGCYCCGG-3´ 3136.6 3136.7 
ON1P 5´-GCGCPCCGG-3´ 3058.6 3058.6 
ON1Z 5´-GCGCZCCGG-3´ 3073.6 3073.6 
ON1Q 5´-GCGCQCCGG-3´ 3074.6 3074.6 
    
    
    
ON1A 5´-GCGCACCGG-3´ 2993.6 2993.8 
ON2U 5´-CCGGUGCGC-3´ 2970.6 2970.8 
ON2A 5´-CCGGAGCGC-3´ 2993.6 2993.8 
ON2G 5´-CCGGGGCGC-3´ 3009.6 3009.8 
ON2C 5´-CCGGCGCGC-3´ 2969.6 2969.8 
ON2S 5´-CCGGSGCGC-3´ 2830.5 2830.6 
    
    
    
ON3U 3´-CGCAUAGCC-5´ 2938.6 2938.8 
ON3A 3´-CGCAAAGCC-5´ 2961.6 2961.8 
ON3G 3´-CGCAGAGCC-5´ 2977.6 2977.8 
ON3C 3´-CGCACAGCC-5´ 2937.6 2937.8 
    
    
















Scheme 11. Acetylation of the 1-methyl-2-(trifluoroacetyl)hydrazinyl groups of the 
modified nucleoside 14 during Ac2O capping  and removal of the trifluoroacetyl groups 
by ammonolysis. Reagents and conditions: a) conventional Ac2O capping; b) 







Scheme 12. Displacement of a dimethylpyrazol-1-yl group with ammonia during 










Table 6. Structures and m/z valuesa of the unmodified and terminally modified 2´-O-
Me-ORN oligonucleotides used in this study. 
 Sequence m/z (absd.) m/z (calcd.) 
 
ON4UA 5´-UGCGCA-3´ 1956.4 1956.4 
ON4AA 5´-AGCGCA-3´ 1979.4 1979.4 
ON4GA 5´-GGCGCA-3´ 1995.3 1995.4 
ON4CA 5´-CGCGCA-3´ 1955.4 1955.4 
ON4UX 5´-UGCGCX-3´ 2115.5 2115.5 
ON4AX 5´-AGCGCX-3´ 2138.5 2138.5 
ON4GX 5´-GGCGCX-3´ 2154.4 2154.5 
ON4CX 5´-CGCGCX-3´ 2114.4 2114.5 
ON4UZ 5´-UGCGCZ-3´ 2036.4 2036.4 
ON4AZ 5´-AGCGCZ-3´ 2059.5 2059.5 












ON4CZ 5´-CGCGCZ-3´ 2035.4 2035.4 
ON5UA 5´-UGCACA-3´ 1940.4 1940.4 
ON5AA 5´-AGCACA-3´ 1963.4 1963.4 
ON5GA 5´-GGCACA-3´ 1979.4 1979.4 
ON5CA 5´-CGCACA-3´ 1939.4 1939.4 
ON5UX 5´-UGCACX-3´ 2099.4 2099.5 
ON5AX 5´-AGCACX-3´ 2122.5 2122.5 
ON5GX 5´-GGCACX-3´ 2138.5 2138.5 
ON5CX 5´-CGCACX-3´ 2098.5 2098.5 
ON5Xa 5´-UCAGX-3´ 1781.4 1781.4 
ON5Xb 5´-UGAGX-3´ 1821.4 1821.4 
ON6X 5´-ACGGCX-3´ 2139.5 2139.5 
ON7X 5´-CGGCX-3´ 1796.3 1796.4 
ON8X 5´-GGCX-3´ 1477.3 1477.4 
    a By ESI-MS using a negative ion mode. 
 
3.3.3 Preparation of pyrrolo-dC-containing RNA targets 
 
The single-strand fluorescent 2´-O-Me-ORNs (ON22, ON23, and ON2C*) and 
TAR RNA models (ON24, ON25 and ON26) were prepared on an automated 
synthesizer using commercial pyrrolo-dC phosphoramidite (3-{5´-O-(4,4´-
dimethoxytrityl-3´-O-[(2-cyanoethoxy)(diisopropylamino)phosphanyl]}-β-D-erthro- 
pentofuranosyl)-3,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one) for introduction 
of the fluorophore (Table 7). Otherwise, commercial 2´-O-Me-ORN building 
blocks were used for the assembly of ON22, ON23 and ON2C*. The chain was 
assembled as described above. The TAR RNA models were assembled from 
commercial 5´-O-DMTr-2´-O-TBDMS-protected 3´-phosphoramidite building 
blocks, but using two consecutive 2´-O-methyl ribonucleotides at both ends of 
the chain to enhance stability of the stem section and to protect the models 
against cleavage by exonucleases. For the synthesis of single-stranded targets, 






TAR RNA models were deprotected with the mixture of ethanol and 33% aq. 
NH3 (1:3, v/v) at 55 °C for 16 h, followed by removal of the TBDMS groups with 
1.53 M triethylamine trihydrofluoride in dry DMSO (2 h at 55 °C). The 2´-O-
methylated oligonucleotides were ammonolyzed as described above. All the 
oligonucleotides were purified and characterized, and their concentration was 
determined as indicated above.119,120   
Table 7. Structures and m/z valuesa of the unmodified and modified RNA 
oligonucleotides used in fluorometric studies. Lowercase letters refer to ribonucleotide 
and capital letters to 2´-O-Me-ribonucleotide residues. X stands for modified nucleoside 
1 (see Table 6) and C* for pyrrolo-2´-deoxycytidine residue. 
Oligonucleotide sequence m/z (obsd.) m/z (calcd.) 
ON19               5´-AAUGCAGUGCCGUAA-3´ 5008.4 5008.0 
ON20               5´-UUACGGCACUGCAUU-3´ 4921.7 4921.9 
ON21               5´-AAAAAAAAAAAAAAA-3´ 5085.5 5085.2 
ON22               5´-AAUGCAGUGC*CGUAA-3´ 5015.7 5015.8 
ON23               5´-AAUGC*AGUGCCGUAA-3´ 5015.7 5015.8 
ON2C*            5´-CCGGC*GCGC-3´ 2978.6 2978.8 
 
ON24              
 
9368.6 9368.2 
   
ON25 
            
9368.6 9368.2 
  
ON26             
9368.6 9368.1 
 a By ESI-MS using a negative ion mode. 
 
 
3.4 NMR spectrometric titrations  
The binding affinity and selectivity of the modified nucleoside 1 towards a 
natural uridine nucleoside in the presence and absence of Pd2+ was studied by 1H 
NMR spectrometric titration. The NMR spectra were obtained in a 120 mM 
deuterated phosphate buffer at pH 7.3, the initial concentration for 1 and uridine 
being 3.6 mM and that of Pd2+ ion 2.5 mM (0.7 equiv.). The titration was 
performed by stepwise dilution of the sample with buffer until the concentration 
of uridine and the modified nucleoside 1 was 0.061 mM (Figure 16). At each 
concentration, two sets of signals for uridine can be clearly distinguished: one 
referring to the free nucleoside and the other to the putative ternary complex 
(Figure 16A-D). The two sets were particularly well resolved in the case of the 
H5 and H1´ resonances of uridine and the integrals of these signals were used to 




To ensure that the detected change in the chemical shifts of the H5 and H1´ of 
uridine was not due to coordination of  Pd2+ alone, a similar titration was also 
carried out in the absence of the artificial nucleoside 1 (Figure 16F-I). As seen in 
Figure 16, the upfield change in the chemical shifts of the H5 and H1´ of uridine 
in the presence of Pd2+ without 1 was in striking contrast to the downfield shift 
associated with the formation of the assumed ternary complex. Furthermore, the 
signals of complexes between uridine and Pd2+ were much weaker than those of 
the ternary complex between uridine, Pd2+ and 1 under the same conditions. The 
modified nucleoside 1 exhibited high affinity for Pd2+, as evidenced by the 
marked downfield shift of the signals of the hydrogens of the pyrazole rings and 




Figure 16.  1H NMR spectra of uridine (H5 and H1´) at various concentrations of 
uridine, 1 and Pd2+ at pH 7.3. (A) [Urd] = [1] = 3.6 mM, [Pd2+] = 2.52 mM; (B) [Urd] 
= [1] = 1.49 mM, [Pd2+] = 1.04 mM; (C) [Urd] = [1] = 0.57 mM, [Pd2+] = 0.40 mM; 
(D): [Urd] = [1] = 0.061 mM, [Pd2+] = 0.042 mM; (E): [Urd] = [1] = 13.84 mM, 
[Pd2+] = 0;	(f)[Urd] = 3.6 mM1, [Pd2+] = 2.52 mM; (g) [Urd] = 1.49 mM, [Pd2+] = 
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Figure 18.  1H NMR spectra of the artificial nucleoside 1; A: [1] = 3.6 mM, [Pd2+] = 
2.52 mM; B: [1] = 3.6 mM, [Pd2+] = 0; The spectra were measured in a 120 mM 
deuterated phosphate buffer at pH 7.3. 
 
As seen in Figure 16A-D, dilution of the sample was accompanied by decrease of 






























[Urd] = [1] / mM
Figure 17. Mole fraction of 
uridine engaged in the 
complex 1:Pd2+:U as a 
function of the concentration 






lowest concentration used (61 µM), the mole fraction of the complex was more 
than 80% of the saturation level observed at high concentration (Figure 17). In 
contrast, no complex was formed between uridine and 1 in the absence of Pd2+ 
even at relatively high (13.84 mM) concentration of the nucleosides (Figure 
16E). 
Accordingly, on the basis of 1H NMR titration, Pd2+ forms a (1+3) type ternary 
complex, 1:Pd2+:U, by binding to N1 of the purine ring and N2 of the pyrazolyl 
moieties of the modified nucleoside 1 and to N3 of uridine. Rotation around the 
Pd2+-N3(uridine) bond allows the minimization of steric crowding with the 
pyrazolyl methyl groups (Figure 19).124  In this regard, the most stable 
conformation is when the bases are perpendicular to each other (Figure 19B).26 In 
the double helix due to base stacking, on the other hand, coplanar geometry is 




Figure 19.  Ternary complex between artificial nucleoside 1, Pd2+ and uridine and 
rotation around the Pd2+-N3(U) bond in.119 
 
3.5 Melting temperatures of oligonucleotide duplexes incorporating 
metal-ion-mediated base pairs 
2´-O-Me-ORNs were used as mimics of RNA in the present study, because they 
are hydrolytically much more stable than native ORNs. The temperature is 
increased above 90 °C during the measurements of duplex melting temperatures 
and, hence, the risk of metal ion promoted cleavage of phosphodiester linkages is 
real.  The length of ONs was adjusted such that the melting temperature in all 
cases would be between 20 and 80 °C. The shorter ONs (6-mer-RNA, Table 6) 
were designed to form  homoduplexes bearing two terminal metallo base pairs, 
which were anticipated to stabilize the double helix more than a single non-






3.5.1 Impact of a single metallo base pair in a non-terminal position 
within the duplex  
The melting temperatures (Tm) of the duplexes between modified (ON1i; i = X, 
Y, Z, P, Q) and unmodified (ON2i, i = U, A, G, C) 9-mer 2´-O-Me-ORNs were 
measured in the presence and absence of divalent metal ions. For comparison, the 
Tm values of the duplexes of unmodified ON1A (containing A instead of the 
modified nucleoside with the unmodified oligonucleotides ON2i (i = U, A, G, C) 
were also determined (Table 8). To find out, whether increasing flexibility in the 
vicinity of the metallo base pair stabilizes the duplex, a mismatch was introduced 
to both sides of the metallo base pair. In other words, Tm values were measured 
for the duplexes that ON1X and ON1A formed with their mismatched 2´-O-Me-
ORNs (ON3i, i  = U, A, G, C) in the presence and absence of metal ions (Table 
9). To distinguish between the contributions of base pairing and stacking to RNA 
stabilization by a metallo base pair, respective measurements were performed 
using ON2S as the  complementary strand with an abasic site in duplexes formed 



























Table 8. Melting temperatures for the duplexes between non-terminally modified 2´-O-
Me-ORNs (ON1i containing a modified nucleoside N2 = X, Y, Z, P, Q in a central 
position) with unmodified 2´-O-Me-ORNs (ON2i containing any nucleoside, N1 = U, 
A, G, C, opposite to the modified one in ON1i). The values in parentheses refer to the 
change in Tm on introduction of metal ions. pH = 7.4 (20 mM cacodylate buffer); 











X 61.8 ± 0.4 61.4 ± 0.4 61.6 ± 0.3 60.7 ± 0.2 69.2 ± 0.3 
Y 42.5 ± 0.4 44.9 ± 0.2 45.4 ± 0.2 47.2 ± 0.3 - 
A 75.1 ± 0.3 56.3 ± 0.2 61.2 ± 0.3 59.0 ± 0.2 55.6 ± 0.3 
P 51.9 ± 0.4 53.1 ± 0.4 53.0 ± 0.4 50.1 ± 0.5 58.3 ± 0.2 
Q 67.0 ± 0.6 66.5 ± 0.8 66.1 ± 0.8 66.3 ± 0.6 69.3 ± 0.4 





X 68.3 ± 0.2 (+6.5) 70.9 ± 0.7 (+9.5) 64.4 ± 1.6 (+2.8) 74.1 ±0.1(+13.4) 70.2 ± 0.5(+1.0) 
Y 43.2 ± 0.8 (+0.7) 44.5 ± 0.5  (-0.4) 45.3 ± 0.3 (-0.1) 50.7 ± 3.0 (+3.5) - 
A 75.8 ± 0.1 (+0.7) 58.8 ± 0.3 (+2.5) 62.5 ± 0.1 (+1.3) 61.7 ± 0.2 (+2.7) 55.6 ± 0.2 (+0) 
P 58.7 ± 0.8 (+6.8) 54.5 ± 0.5 (+1.4) 56.3 ± 0.6 (+3.3) 53.3 ± 0.6 (+3.2) 58.0 ± 0.3 (-0.3) 
Q 72.2 ± 0.3 (+5.2) 75 ± 2 (+8.5) 72 ± 1 (+5.9) 73 ± 2 (+6.7) 69.6 ± 0.4(+0.3) 





X 65.0 ± 1.0 (+3.2) 69.9 ± 3.0 (+8.5) 63.6 ± 0.8 (+2.0) 68.3 ± 2.0 (+7.6) 69.1 ± 0.4 (-0.1)  
Y 42.3 ± 0.4 (-0.2) 45.7 ± 0.2 (+0.8) 45.7 ± 0.6 (-0.3) 45.7 ± 0.3 (-1.5) - 
A 76.0 ± 0.3 (+0.9) 56.4 ± 0.2 (+0.1) 62.3 ± 0.1 (+1.1) 61.4 ± 0.1 (+2.4) 55.4 ± 0.2 (-0.2) 
P 51.8 ± 0.4 (-0.1) 52.8 ± 0.8 (+0.9) 54.0 ± 0.8 (+1.0) 51.3 ± 0.6 (+1.2) 58.4 ± 0.1(+0.1) 
Q 74 ± 2 (+7.0) 73 ± 2 (+6.5) 73 ± 2 (+6.9) 72 ± 2 (+5.7) 69.4 ± 0.1(+0.1) 




 X 60.6 ± 0.6 (-1.2) 61.6 ± 0.1 (+0.2) 60.1 ± 0.6 (-1.5) 59.9 ± 0.4 (-0.8) - 
Y 42.4 ± 0.5 (-0.1) 47.5 ± 1.6 (+2.5) 45.7 ± 0.9 (+0.3) 50.7 ± 3.2 (+3.5) - 
A 73.7 ± 0.1 (-1.4) 56.3 ± 0.1 (+0) 60.4 ± 0.1 (-0.8) 58.8 ± 0.2 (-0.2) - 




















Table 9. Melting temperatures for the mismatched duplexes of non-terminally modified 
2´-O-Me-ORNs ON1i (N2 = X or A) with 2´-O-Me-ORNs (ON3i; N1 = U, A, G, C) 
containing any nucleotide opposite to X or A in ON1i. The values in parentheses refer 
to the change in Tm values on introduction of metal ions. pH = 7.4 (20 mM cacodylate 
buffer); [oligonucleotides] = 3.0 M; [metal ions] = 0 or 3.0 M; I(NaClO4 = 0.10 M). 
 
 
  N1 
M2+ N2 U A G C 
no 
metal 
X 60.4 ± 0.3 (-1.4) 61.0 ± 0.9 (-0.4) 61.8 ± 0.4 (+0.2) 60.3 ± 0.5 (-0.4) 
A 26.9 ± 0.3 (-48.2) 43.6 ± 0.7 (-12.7) 44.3 ± 0.3 (-16.9) 45.7 ± 0.8 (-13.3) 
Cu2+ 
X 72.6 ± 0.2 (+12.2) 71.9 ± 0.9 (+10.9) 72.6 ± 0.6 (+10.8) 72.4 ± 0.3 (+12.1) 
A 28.6 ± 0.1 (+1.7) 43.8 ± 0.5 (+0.2) 43.8 ± 0.5 (-0.5) 41.3 ± 0.5 (-4.4) 
Zn2+ 
X 64.4 ± 0.3 (+4.0) 63.8 ± 0.6 (+2.8) 62.8 ± 0.2 (+1.0) 63.9 ± 0.8 (+3.6) 
A 26.7 ± 0.4 (-0.2) 41.7 ± 0.3 (-1.9) 51.2 ± 0.2 (+6.9) 42.8 ± 0.2 (-2.9) 
Pd2+ 
X 60.4 ± 0.1 (+0) 61.7 ± 0.9 (+0.7) 60.1 ± 0.2 (-1.7) 61.1 ± 0.3 (+0.8) 
A 27.6 ± 0.1 (+0.7) 44.3 ± 0.6 (+0.7) 43.5 ± 0.9 (-0.8) 43.9 ± 0.7 (-1.8) 
 
 
In all cases, the Tm values were measured in a 20 mM cacodylate buffer at pH 7.4 
in the presence and absence of Cu2+, Zn2+ ions. In the case of ON1X, ON1Y and 
ON1A, measurements were additionally carried out in the presence of Pd2+. The 
ionic strength was adjusted to 0.1 M with NaClO4 and the concentration of the 
each ON was 3.0 µM. The concentration of CuSO4, Zn(NO3)2 or K2PdCl4 was 
either 0 or 3.0 µM. 
All results of UV thermal denaturation experiments with 9-mer ONs are 
summarized in Tables 8 and 9. In the absence of divalent metal ions, the most 
stable duplex was formed between unmodified ONs ON1A and ON2U, having a 
Watson-Crick A:U base pair in the middle of the sequence (Table 8). None of the 
modified ORNs displayed duplex stability of the same magnitude. However, 
while a non-complementary base (A, C or G) opposite to A diminished Tm by 14 
-20 oC, the modified nucleosides were insensitive to the identity of the opposing 
nucleoside; no selectivity was observed. In fact, hybridization with ON2S, 
containing an abasic site opposite to the modification, was more efficient, 
whereas omission of the opposing  base destabilized the duplex with ON1A more 
markedly than any of the mismatched bases. 
Addition of 1 equiv. of Cu2+ changed the situation completely: the duplexes 
formed by ON1X and ON1Q were stabilized, whereas the duplexes formed by 
ON1A remained essentially unaffected. In particular, all duplexes of ON1Q, 
except ON1Q:ON2S, were approximately as stable as the fully matched 




were stabilized to a much lesser extent. Interestingly, ON1X showed some base 
selectivity, the ΔTm values obtained for opposing bases (compared to the 
situation in the absence of metal ions) being 13.4, 9.5, 6.5, 2.8 and 1.0 for C, A, 
U, G and abasic site, respectively. With the other modified nucleosides studied, 
the selectivity was weaker. The effect of Cu2+ was not observed at all with 
duplexes formed by ON2S.  
Zn2+ stabilized the duplexes of ON1Q approximately as efficiently as Cu2+. With 
ON1X, Zn2+ was somewhat less stabilizing than Cu2+, but retained the base-
selectivity for A and C . Only very modest stabilization, if any, was observed 
with the other modified ORNs. None of the duplexes with ON2S was stabilized 
by Zn2+.   
Somewhat unexpectedly, Pd2+ ion had virtually no effect on recognition of 
unmodified ORNs (ON2i) with modified ORNs, ON1X and ON1Y.  
The metal-ion-binding base surrogates used in the present study are rather bulky, 
which may hinder their accommodation inside the rigid base-stacked area 
between two fully matched base pairs. To make the structure more flexible, one 
mismatch was introduced on both sides of the metallo base pair. The melting 
temperatures were measured for duplexes formed by ON1X and ON1A with 
their mismatched complements ON3i (i = U, A, G, C) under the conditions 
indicated above for the duplexes with ON2i (i = U, A, G, C) (Table 5 and 9).   
The effect of two mismatches is evident with the duplexes formed by the 
unmodified oligonucleotide ON1A; the melting temperatures dramatically 
decrease both in the absence or presence of divalent metal ions. In contrast, 
hybridization of ON1X in the absence of divalent metal ions was unaffected by 
the neighboring mismatches and addition of Cu2+ greatly enhanced the stability. 
Unfortunately, the hybridization did not show any base selectivity. The ΔTm was 
(11 ± 1) °C independently of the identity of the opposing base. Only a very 
modest effect was observed with Zn2+ and no effect at all with Pd2+. 
 
3.5.2 Impact of two terminal metallo base pairs 
To minimize the steric constraint of the neighboring Watson-Crick base pairs, the 
metal-ion-mediated base pairing was next studied in a terminal position: the Tm 
values were measured for self-complementary 6-mer 2´-O-Me-ORNs bearing the 
modified residue at the 3´-terminus. Both matched ONs (ON4Xi and ONZi, i = 
U, A, G, C) and mismatched ONs (ON5Xi, i = U, A, G, C) were studied in the 
absence and presence of divalent metal ions under the conditions used above 






unmodified matched (ON4Ai, i = U, A, G, C) and mismatched (ON5Ai, i = U, 
A, G, C) 2´-OMe-ORNs were measured under the same conditions. The Tm 
values obtained are summarized in Table 10 and 11.    
Table 10. Melting temperatures for the duplexes formed by the self-complementary 
modified (N2 = X, Z,; N1 = U, A, G, C) and unmodified 6-mer 2´-O-Me-ORNs (N2 = 
A; N1 = U, A, G, C). The values in parentheses refer to the change in Tm on introduction 
of metal ions; pH = 7.4 (20 mM cacodylate buffer); [oligonucleotides] = 3.0 M; [metal 










 X 44.2 ± 0.6 43.9 ± 1.5 46.9 ± 0.2 44.1 ± 0.5 
Z 53.5 ± 0.1 54.0 ± 0.3 55.7 ± 0.3 51.8 ± 0.2 




 X 71.8 ± 0.5 (+27.6) 62.5 ± 0.3 (+18.6) 69.4 ± 0.3 (+22.5) 62.7 ± 0.2 (+18.6) 
Z 68.7 ± 0.3 (+15.2) 59.2 ± 0.7 (+5.2) 64.4 ± 0.1 (+8.7) 62.0 ± 0.5 (+10.2) 




 X 51.8 ± 1.0 (+7.6) 50.3 ± 1.8 (+6.4) 52.4 ± 0.1 (+5.5) 48.1 ± 0.5 (+4.0) 
Z 54.3 ± 1.2 (+0.8) 54.4 ± 1.0 (+0.4) 55.2 ± 0.4 (-0.5) 52.9 ± 0.3 (+1.1) 




 X 54.3 ± 0.7 (+10.1) 44.5 ± 0.8 (+0.6) 41.0 ± 0.4 (-5.9) 38.6 ± 1.6 (-5.5) 
Z 56.2 ± 0.8 (+2.7) 56.8 ± 0.2   (+2.8) 57.0 ± 2.0 (+1.3) 51.5 ± 0.4 (-0.3) 
A 39.4 ± 0.3 (+0.2) 36.1 ± 0.3 (-0.7) 35.8 ± 0.6 (-2) 35.1 ± 1.2 (-1.7) 
 
 
As seen in Table 10, the modified self-complementary 6-mer 2´-O-Me-ORNs 
form significantly more stable duplexes than their unmodified counterparts, even 
in the absence of divalent metal ions, in striking contrast to the results of ON1i  
where the modification is non-terminal (see Table 8). In particular, the duplexes 
of ON4Zi (i = U, A, G, C) having 2-(3,5-dimethyl-pyrazol-1-yl)adenine (5) as 
the modified nucleoside are remarkably stable.  
Addition of Cu2+ stabilized the duplexes ON4XU and ON4XG by nearly 28 and 
23 °C, respectively. By contrast, only a modest increase in Tm was observed with 
the unmodified counterparts ON4AU and ON4AG. The stabilization was base-
selective with both X and Z. The Z containing ONs Z exhibited higher U-
selectivity although they formed weaker duplexes. Accordingly, with the 6-mer 
duplexes bearing terminal modifications, the metal-ion-mediated binding is U- 
rather than C-selective, while non-terminal modifications of the 9-mer duplexes 




marked difference compared to the behavior of the non-terminally modified 9-
mers is that the presence of Pd2+ significantly and selectivity enhances the 
thermal stability of ON4XU duplex by increasing the melting temperature by 10 
°C.  
The greatly enhanced hybridization of the self-complementary 6-mer 
oligonucleotides bearing terminal metallo base pairs could have been achieved at 
the cost of reduced base-selectivity in the central part of the duplex. In other 
words, the thermal stability of these duplexes might solely result from 
exceptionally high stability of the metal-ion-mediated base pairs. To investigate 
this possibility, melting temperatures of a series of 6-mer 2´-O-Me-ORNs with 
two consecutive mismatches in the middle of the sequence (ON5Xi and ON5Ai, 
i = U, A, G, C)  were measured under the conditions used for the other ONs 
(Table 10). As seen by comparison of the values in Tables 10 and 11, the Tm 
values of the mismatched duplex (Table 11) are from 25 to 61 °C lower than 
those of their matched counterparts (Table 10), irrespective of the presence of 
divalent metal ions. Obviously even the short metallo oligonucleotides retain the 
sequence selectivity of the unmodified sequence, regardless of strong 
stabilization by the two terminal metallo base pairs. 
 
Table 11. Melting temperatures for the duplexes formed by the self-complementary 
modified (N2 = X; N1 = U, A, G, C) and unmodified (N2 = A; N1 = U, A, G, C) 
mismatched 6-mer 2´-O-Me-ORNs. The values in parentheses refer to the change in Tm 
on introduction of metal ions. pH = 7.4 (20 mM cacodylate buffer); [oligonucleotides] = 




M2+ N2 U A G C 
no 
metal 
X 11.2 ± 0.2 14.3 ± 0.3 N/Ag N/Ag 
A 10.9 ± 0.1 10.3 ± 0.1 12.0 ± 0.5 12.4 ± 0.4 
Cu2+ 
X 10.6 ± 0.3 11.7 ± 1.2 10.7 ± 0.5 10.3 ± 0.1 
A 10.3 ± 0.1 10.4 ± 0.1 12.3 ± 1.3 13.7 ± 0.8 
Zn2+ 
X 10.4 ± 0.2 10.7 ± 0.5 10.1 ± 0.1 10.2 ± 0.2 
A 10.3 ± 0.1 10.3 ± 0.1 10.5 ± 0.1 10.6 ± 0.3 
Pd2+ 
X 10.6 ± 0.3 10.5 ± 0.2 10.7 ± 0.4 10.9 ± 0.5 
A 10.4 ± 0.1 10.2 ± 0.1 10.3 ± 0.2 10.5 ± 0.4 

















































3.6 CD spectroscopic studies for hybridization properties 
To obtain additional information about the helicity of the oligonucleotide 
duplexes formed in the presence of divalent metal ions, CD spectra121 for all the 
duplexes were measured over a wide temperature range from 6 to 94 °C under 














Figure 20. (A) CD spectra of the ON1Z:ON2C duplex in the presence of Cu2+, 
recorded at 4 °C intervals between 6-94 °C and (B) thermal hyperchromicity at 260 nm 
(solid line) and loss of ellipticity () of the same duplex; [ON1Z] = [ON2C] = [Cu2+] 










































The CD spectra of both the 9-mer (Figure 20A) and 6-mer (Figure 21A) 
oligonucleotides were at low temperatures characteristic for an A-type duplex. 
Gradual diminishing of the CD signal was detected on increasing the 





















Figure 21. (A) CD spectra of the duplex formed by the self-complementary modified 
oligonucleotide ON4UX  in the presence of Cu2+, recorded at 4 °C intervals between 6-
94 °C and (B) thermal hyperchromicity at 260 nm (solid line) and loss of ellipticity () 










As illustrated in Figures 20B and 21B, the loss of ellipticity of CD spectra 
depended sigmoidally on temperature exhibiting the same inflection point as the 
UV-melting curves. 
 
3.7 Fluorescence spectrometric studies  
In this study, the hybridization of modified metal-ion-binding oligonucleotides 
with their natural counterparts was examined by using a fluorescent 
pyrrolocytosine nucleobase (3,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one) as 
an  indicator of hybridization.128,129 The reason for utilization of fluorescence 
intensity as the detection method was that the purpose was to examine the 
interactions with the motives of TAR secondary structure. The fluorescent 
pyrrolo-dC nucleoside was incorporated within a TAR RNA model. TAR 
structure includes several double-helical regions, which gives extremely 
complicated UV melting profiles, therefore the pyrrolo-dC nucleoside was also 






















Figure 22. Metallo base pair formation between the single-stranded oligonucleotides 
ON22 (A) and ON23 (B), containing pyrrolo-dC nucleoside in different places within 
the strand, with short modified (ON6X, ON7X and ON8X) and fully complementary 
(ON20) oligonucleotides. With ON22, the pyrrolo-dC fluorescence is excepted to be 




As a proof of concept, the fluorometric studies were first performed with 15-mer 
2´-O-Me-ORNs containing the fluorescent pyrrolo-dC in two different sites 
within the ON strand (Figure 22).  
 
3.7.1 Fluorescence spectroscopy results of metal-ion-mediated base-
pairing with single-stranded oligonucleotides 
The intensity of fluorescence emission of ON22 and ON23 as single strands and 
hybridized with their short modified 6-, 5- and 4-mer complements (ON6X, 
ON7X and ON8X, respectively) in the presence or absence of 1 equiv. of Cu2+ 
was recorded. The excitation and detection wavelengths were 337 nm and 460 
nm, respectively (Figure 23). For maximal quenching of pyrrolo-dC 
fluorescence, the measurement was also carried out by using the full length 
ON20 as a complement. In addition, the fluorescence emission intensity of 
ON22 and ON23 was measured in the presence of a 15-mer oligo(A), used as a 
model of a non-complementary ON (Table 7). The fluorescence spectra were 
obtained in a 20 mM cacodylate buffer at pH 7.4, where ionic strength was 
adjusted with NaClO4 to 0.10 M. The concentration of the oligonucleotides and 
Cu2+ (as CuSO4) was 2.0 µM. The fluorescence emission intensities for the 
various oligonucleotide assemblies in the presence and absence of Cu2+ are 
presented in Figure 23. Furthermore, the effect of transient intramolecular base-
stacking or base-pairing of the single-stranded ONs (ON22 and ON23) on the 
fluorescence of pyrrolo-dC was estimated by measurements under the same 
conditions in the presence of formamide (40%, v/v) as a denaturant.  
In the absence of divalent metal ions, oligonucleotides ON22 and ON23 
exhibited strong emission at 460 nm. In both cases, the emission was 
substantially quenched upon  formation of a duplex with a full length 
complementary ON20. This behavior was expected since the fluorescent pyrrolo-
dC nucleoside became engaged in a double helix. The quenching was somewhat 
more efficient with ON23 than with ON22. The mismatched oligonucleotide 
ON21, in turn, had no influence on the fluorescence emission of ON22 and 
ON23. 
On using shorter complementary ONs (ON6X, ON7X, ON8X) that still 
hybridized with a sequence containing pyrrolo-dC in ON22, the quenching 
gradually decreased with decreasing the length of the complementary ON. In the 
case of ON23, where the pyrrolo-dC residue is placed outside the sequence 
engaged in the double helix with these short ONs, the fluorescence emission 
remained unchanged or was even increased on hybridization. With the 6-mer 






approximately at the level of single-stranded ON23. It is worth noting that a 
marked increase in fluorescence intensity of both ON22 and ON23 was detected 
in the presence of formamide. This suggests that the fluorescence of pyrrolo-dC 
was also quenched to some extent within a single-stranded ON, most likely due 
to base-stacking. 
    





















Figure 23. Fluorescence intensity of the pyrrolo-dC residue contained by ON22(A) and 
ON23 (B) and their duplexes with ON6X, ON7X, ON8X, ON21 and ON22 in the 
absence (hashed bars) and presence of Cu2+(gray bars); T = 25 °C; pH = 7.4 (20 mM 
cacodylate buffer); I(NaClO4) = 0.10 M; [oligonucleotides] = 2.0 µM; [Cu2+] = 0 or 
2.0 µM; ex = 337 nm; em = 460 nm. FA= formamide. 
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Addition of 1 equiv. of Cu2+ quenched the fluorescence of both ON22 and 
ON23, as well as their duplexes with the short 4-, 5-, and 6-mer ONs by 10-15%. 
This change may well be attributed to the coordination of Cu2+ ion with pyrrolo-
dC base, which to some extent quenches the fluorescence emission. 
In addition to this common reduction in fluorescence, the fluorescence of 
ON22:ON6X, ON22:ON7X and ON22:ON8X was still additionally quenched 
by 20-30%, most probably because of stabilization by a metal-mediated base 
pair. In striking contrast to the situation in the absence of Cu2+, the shortest 
modified ON (ON8X) in the presence of Cu2+ quenched the fluorescence by 
40%, approaching the quenching obtained with the fully complementary duplex 
ON22:ON20. A similar enhanced quenching was not observed upon 
hybridization of ON6X, ON7X and ON8X with ON23, having pyrrolo-dC 
outside the double helical region. 
Formation of a Cu2+-mediated base pair may result in a bathochromic shift in the 
UV absorbance, which might lead to absorption at the excitation wavelength and, 
hence, quenching. To clarify this issue, the titration analysis of the UV spectrum 
of modified nucleobase X by CuSO4 was performed (Figure 24).  
 












Figure 24. UV spectrum of the modified nucleoside X (10 µM) in the presence Of 0 
(blue line), 0.5, 1.0, 1.5, 2.0, 5.0 and 10.0 equiv.(black line) of CuSO4; T = 25 °C; pH = 
7.4 (20 mM cacodylate buffer); I(NaClO4) = 0.10 M.128 
 
As seen, hyperchromic changes at 250 and 330 nm and hypochromic change at 
270 nm were detected on addition of Cu2+. The same investigation was also 
performed with ON19:ON6X with identical results. According to these results, 






the fluorometric measurements has only a negligible influence on the results 
(approximately 0.01 AU).128   
The data obtained by fluorescence spectroscopy for hybridization of the linear 
ONs of various lengths was verified by comparative melting temperature 
measurements for all duplexes under the conditions used in the fluorescence 
emission studies. The results are summarized in Table 12.  
 
Table 12. Melting temperatures of the hybridization of the fluorescent oligonucleotides 
ON22 and ON23 with the short metal-ion-chelating oligonucleotides ON6X, ON7X 
and ON8X and the fully complementary unmodified oligonucleotide ON20 in the 
presence and absence of Cu2; [oligonucleotides] = 2.0 μM; [Cu2+] = 0/2.0 μM; 
I(NaClO4) = 0.1 M; pH = 7.4 (20 mM cacodylate buffer). 
 ON22 ON23 
 Without Cu2+ With Cu2+ Without Cu2+ With Cu2+ 
ON8X 10.8 ± 0.5 28.6 ± 0.4 (+17.8) 11.1 ± 0.7 29 ± 3 (+17.9) 
ON7X 27.6 ± 1.3 51.5 ± 0.3 (+23.9) 25.3 ± 0.8 51.9 ± 0.5 (+26.6) 
ON6X 42.9 ± 0.2 54.6 ± 1.6 (+11.7) 41.9 ± 0.3 55.3 ± 0.4 (+13.4) 
ON20 74.0 ± 0.3 74.6 ± 0.2 (+0.6) 70.9 ± 0.3 71.9 ± 0.1 (+1.0) 
 
The results were consistent with the previous observations on short self-
complementary oligonucleotides containing the metal-ion-binding nucleoside-X 
at the 3´-end (Table 10). The Tm values expectedly rose with the increasing 
length of the short modified oligonucleotides. Nearly similar results were 
obtained with ON22 and ON23, as expected for two almost identical 
oligonucleotides differing only in the place of the pyrrolocytosine base. The 
pyrrolocytosine base well imitates the native cytosine in Watson-Crick base 
pairing. To verify this, the Tm was measured for duplex ON19:ON20, with 
canonical C nucleoside instead of pyrrolo-dC. The Tm value obtained (75.5°C) 
was very close to the one of ON22:ON20 (74.0 °C).  
The influence of Cu2+-mediated base pairing of pyrrolocytosine on its 
fluorescence was also studied with ONs containing the Cu2+-binding nucleoside 
X and pyrrolo-dC in a complementary non-terminal position. The fluorescence 
intensity measurements were carried out for duplex ON1X:ON2C* (Figure 25). 
The stability of a similar duplex containing C in place of C* had been previously 














Figure 25. Fluorescence intensity of the pyrrolo-dC nucleoside in middle of ON2C ⃰ and 
its duplex with ON1X in the absence (hashed bars) and presence of Cu2+(gray bars); T 
= 25 °C; pH = 7.4 (20 mM cacodylate buffer); I(NaClO4) = 0.10 M; [oligonucleotides] 




The fluorescence emission of ON2C* was similar to that of the single-stranded 
15-mer oligonucleotides ON22 and ON23, both in the presence and in the 
absence of Cu2+ (Figure 25). The fluorescence of the duplex ON1X:ON2C* was, 
in turn, very different, the emission being more than two times as high as that of 
single-stranded ON2C*. The probable explanation for this large increase of 
emission is that the bulky 2,6-bis(3,5-dimethylpyrazol-1-yl)purine base forces 
the pyrrolocytosine out of the double helix,  exposing it even more than in single-
stranded ON2C* (Scheme 13). The same effect has been observed for complexes 
of the methyl-specific endonuclease McrBC with unnatural pyrrolo-dC-
containing ONs, in which case flipping out of the cytosine base was also proved 
by X-ray crystallography.130 Addition of Cu2+ quenched markedly the 
fluorescence intensity, comparable to the level observed with ON22:ON6X, 
ON22:ON7X or ON22:ON8X (see Figure 23A). Evidently through formation of 
the Cu2+-mediated base-pair between pyrrolocytosine and 1, the pyrrolocytosine 
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Scheme 13. Pyrrolocytosine deflected out of the double-strand because of bulkiness of 
artificial nucleoside X and again accommodated in the double helix by Cu2+-mediated 
base pairing between C*and X. 
 
 
3.7.2 Hybridization and recognition of the bulge motif of TAR RNA by 
short metallo oligonucleotides 
 
To study the hybridization selectivity of short metal-ion-binding ONs towards 
the bulge region (UCU) of TAR RNA, the fluorescence of the three models 
(ON24, ON25 and ON26) with a different placement of the pyrrolo-dC residue 
were measured in the presence and absence of 5-mer 2´-O-Me-ORNs, ON5Xa 
and ON5Xb under the conditions used above for the single-stranded targets 
(Figure 26 and Scheme 14). In ON25 target model, the pyrrolo-dC was located in 
the bulge region (UC*U), while in ON24 and ON26 it was placed within the 
double-helical stem. Therefore, only ON25 was expected to show a clear drop of 
fluorescence emission upon hybridization with fully complementary ON5Xa or 



























Scheme 14. Metal-ion-chelation between short modified oligonucleotides and the bulge 
(UCU ) region of TAR RNA. A pyrrolo-dC nucleoside is incorporated in different places 
of the TAR RNA models. The lowercase letters refer to ribonucleotide and capital letters 
to 2´-O-methylribonucleotide residues, respectively. Pyrrolo-dC in the duplex part is 
expected to be only weakly fluorescent (A and C), whereas pyrrolo-dC in the bulge 







































Figure 26. Fluorescence intensity of the pyrrolo-dC probe in ON24 (A), ON25 (B) and 
ON26 (C) and their duplexes with ON5Xa and ON5Xb in the absence (hashed bars) 
and presence of Cu2+(gray bars); T = 25 °C; pH = 7.4 (20 mM cacodylate buffer); 
I(NaClO4) = 0.10 M; [oligonucleotides] = 2.0 µM; [Cu2+] = 0 or 2.0 µM; ex = 337 
nm; em = 460 nm. 
 
The fluorescence emission of ON24, ON25 and ON26 turned out to be similar in 
the absence of Cu2+, in spite of the fact that pyrrolo-dC is in ON25 situated 




60 80 100 120
 
 
F luo rescence  in tens ity / a .u .
60 80 100 120
 
 
F lu o re sce n ce  in te n s ity  / a .u .
6 0 8 0 1 0 0 1 2 0
 
 




helix. The situation changed when the short fully complementary ON5Xa was 
added: the intensity of ON25 and ON26 was slightly increased, whereas the 
fluorescence of ON24 was unexpectedly decreased by 30% (Figure 26). Addition 
of partly complementary ON5Xb was quenching with all the three models: 30, 8 
and 5% with ON24, ON25 and ON26, respectively.   
On addition of Cu2+, the fluorescence emission of ON25:ON5Xa and 
ON25:ON5Xb was reduced by 25% and 17%, consistent with more efficient 
binding of fully complementary ON5Xa. Among other duplexes, ON26:ON5Xa 
experienced 9% quenching, while the fluorescence of the rest of the duplexes 
remained almost unchanged or modestly increased. These results are consistent 
with the expectations, but the observations that addition of Cu2+ markedly 
reduces the fluorescence of all the targets (ON24-ON26) in the absence of  
ON5Xa,b severely questions the reliability of this approach. In addition, the fact 
that the fluoresence emission of ON24 is markedly reduced by hydridization 
with ON5Xa,b in the absebce of Cu2+ is difficult to explain. In summary, the 
expected strong and selective quenching of the fluoresecence of ON25 in the 
presence of ON5Xa did not come true. The three base bulge (Scheme 14) may 
still be structurally so ordered that its interactions with short probes cannot be 
fully compared to interactions of relaxed single strands. 
 
3.8 Hydrolytic stability of the modified oligonucleotides 
During the release of oligonucleotides ON1X and ON4Xi (i = U, A, G, C) from 
the support and deprotection of the base moieties by concentrated aq. NH3 , some 
displacement of the pyrazolyl substituent at position 6 of the modified nucleoside 
X by NH3 took place (Scheme 12). This questioned the hydrolytic stability of 
ORNs containing the modified residue X at the high temperatures used in the Tm 
measurements. Although water is a weaker nucleophile than NH3, coordination 
of a metal ion to N2 of the pyrazole ring may render the purine ring more 
susceptible to nucleophilic attack. 
To assess the extent of hydrolysis of the modified oligonucleotides under 
conditions of the melting temperature studies, the samples were analyzed by 
HPLC and ESI-MS before and after the measurement (3 cycles from 0 to 90 °C 
and back, with 0.5 °C min-1). The ON1Z, ON1P and ON1Q oligonucleotides 
were shown to be fully stable. ON1X had, however, been partially converted to 
the hydrolysis product ON1Q in the presence of Cu2+ (Scheme 15). In other 
words, the 2,6-bis(3,5-dimethylpyrazol-1-yl)purine (X) base had been converted 









Scheme 15. Hydrolytic conversion of 2,6-bis(3,5-dimethylpyrazol-1-yl)purine residue to 
a 2-(3,5-dimethylpyrazol-1-yl)hypoxanthine residue.119 
 
This transformation was not observed in the presence of Zn2+ or in the absence of 
divalent metal ions with the 6-mer ONs containing X. 



















Figure 27. Logarithmic time profiles for the decomposition of ON5Xa in the absence 
() and presence of Cu2+ () or Zn2+ (); [ON5Xa] = [CuSO4] = [Zn(NO3)2] = 2.0 
M; I(NaClO4) = 0.1 M; pH = 7.4; T = 37 °C.119 
 
To obtain more quantitative data on the hydrolytic stability of oligonucleotides 
containing the modified nucleoside X, kinetic studies were performed with a 5-
mer oligonucleotide, ON5Xa (Figure 27). The reactions were carried out in 20 
mM cacodylate buffer (pH = 7.4) in the absence and presence of 1 equiv. of 




1 with NaClO4 and the starting concentration of ON5Xa was 2.0 M for each 
kinetic run. Potassium 4-nitrobenzenesulfonate was used as an internal standard. 
Aliquots were withdrawn from the reaction solutions at appropriate time intervals 
to cover approximately one half-life and analyzed by RP HPLC. The 
disappearance of the starting material (ON5Xa) obeyed first-order kinetics.  
In all cases, loss of ON5Xa was accompanied by the appearance of a new 
product, which eluted faster. ESI-MS analysis confirmed the product to be 
ON5Q (Scheme 15). The degradation half-lives of ON5Xa in the presence of 
Cu2+ and Zn2+ and in the absence of divalent metal ions at 37 °C were 69, 880 





















4.1 The effect of metal-ion-binding nucleosides in a non-terminal 
position on the duplex stabilty  
4.1.1 The effect of steric and stacking interactions  
Replacement of a non-terminal adenosine with any of the modified nucleosides 
studied (X, Q, P, Z, Y) destabilized the double helix with unmodified 
complementary ONs. With X, Q and Z, the destabilization was, however, lesser 
than that caused by AA, AG and AC mismatches. Modification Y was 
exceptionally destabilizing. One may tentatively assume that hydrazinyl 
substituents do not increase the polarizability of the purine π-electron system as 
much as the aromatic pyrazolyl groups and, hence, stacking with the neighboring 
base pairs is weaker. Destabilization was less prominent when the base opposite 
to the modified base is removed, evidently owing to reduction of steric repulsion. 
In fact, ORNs containing X, Q or Z hybridized better than their A containing 
counterpart with the abasic complement ON2S. Since 2-(3,5-dimethylpyrazol-1-
yl) substituted Q and Z were as destabilizing as their 2,6-disubstituted 
counterpart X, stacking around the C2 seems to be of particular importance. A 
mismatch on both sides of surrogate nucleoside X, which made the structure 
more flexible, did not additionally retard hybridization, while the same 
mismatches on both sides of an AU pair were highly destabilizing. 
 
4.1.2 The effect of metal-ion-mediated base pairing 
In the presence of Cu2+ (1 equiv.), ORNs containing X or Q hybridize 
approximately as efficiently as the fully complementary unmodified ORNs. The 
fact that the Tm values are 3-13 ºC higher than in the absence of Cu2+ may be 
taken as a strong indication of metal-ion-mediated bonding to the opposing 
canonical nucleoside. This conclusion receives further support from the fact that 
duplexes with ORNs bearing an abasic site opposite to the metal-ion-binding 
nucleobase were not stabilized by Cu2+. Mismatches for both sides of the metallo 
base pair still slightly increased stability of the duplex, evidently by reducing 
constraints for formation of the metallo base pair.  
The artificial nucleobases of X, P, Q and Z most likely offer N2 of 
dimethylpyrazolyl ring as a donor atom in addition to N1 or N7 of the purine 
base. The free electron pair on N2 of the pyrazole ring is not part of the aromatic 
-electron system and is, hence, readily available for coordination. Tentatively, 




coordination modes are depicted in Figure 28: binding to N1 and pyrazole-N2 for 
X, Q and Z and to N7 and pyrazole-N2 for P. The recent report on Cu2+ binding 
to N7 of 6-furylpurine 2´-deoxyriboside lends support for the suggested binding 
mode of P.131 The remaining binding sites of Cu2+ in X, Q, Z and P are 
presumably occupied by the ring nitrogens of the opposing canonical base or by 
water. Several IR, EPR and NMR spectrometric and X-ray crystallographic 
studies have established N1 and N7 of purines132-143 and N3 of pyrimidines144-147 
as the favored binding sites for Cu2+.148-152 At physiological pH, adenosine and 
cytidine coordinate mainly through N7 and N3, respectively, and guanosine and 
uridine through deprotonated N1 and N3, respectively. The lone electron pair of 
the oxo substituents is also available for metal ion binding, whereas the lone 
electron pair of the amino groups is involved in the aromatic π-electron system 
and, hence coordination to amino nitrogen is only possible by displacement of a 
proton.153,154 The behavior of Zn2+ largely resembles that of Cu2+, but the binding 









Figure 28. Coordination of Cu2+ by the modified tridentate nucleoside X, and bidentate 
nucleosides Q, Z and P. 
 
The stability of the metal-ion-mediated base pairs appears to correlate with the 
potential of either the natural or the surrogate base to serve as an anionic ligand. 
The greatest elevations in Tm in the presence of Cu2+ or Zn2+ are observed in 
cases where at least one member can deprotonate to give an anion. The natural 
nucleosides guanosine and uridine, and probably the modified nucleoside analog 
Q, may undergo deprotonation upon coordination of Cu2+ or Zn2+ at 
physiological pH (Figure 29). The modified oligonucleotide ON1Q, hence, 












Figure 29. Suggested metal-ion-mediated base pairs between Q and natural 
nucleosides: (A) adenosine, (B) cytidine, (C) guanosine and (D) uridine. 
 
Unlike ON1Q, modified oligonucleotides ON1P and ON1Z are not readily 
deprotonated under the experimental conditions. Accordingly, stable duplexes 
were formed only with oligonucleotides that contained G or U opposite to the 
modified base (Figure 30 and 31). ON1Z made an exception. C was preferred 
over U in the presence of Cu2+. Tm value measurements with complements 
containing A and G failed (no clear inflection point could be obtained), which 
also questions the credibility of the data obtained with the C and U containing 
complements. 
The tridentate metal chelates of X prefer binding to C and A, in contrast to the 
bidentate chelates of P and Q. Since X is more bulky than P, Q and Z containing 
only one pyrazolyl substituent, steric factors may play a more important role with 
this modification. Interactions between the methyl substituents of the pyrazolyl 
moieties and the opposing canonical bases should be taken into account besides 
the electronic effects. The structures depicted in Figure 32 do not, however, offer 
any straightforward explanation for higher stability of planar metal-ion-mediated 
structures with C and A  compared to U and G. As discussed in the section of 
geometry and coordination of this thesis (1.2.2.), many factors influence on the 
stability of planar metal-ion-mediated base pairs between tridentate terpyridine 
and monodentate ligands. Even steric repulsion between hydrogen atoms retards 
formation of a planar structure (see Scheme 2).39 One should also bear in mind 




donor atoms of neighboring base pairs may also contribute to the overall stability 
by serving as axial ligands. In other words, the ligand field may rather be a 
distorted octahedron than purely square planar. The alternative that, owing to 
steric repulsion of the pyrazolyl methyl groups, C (and maybe A) is bound by 
displacement of one of the amino protons should not be strictly excluded, either. 
In other words the donor atom would be N4 (with A N6) instead of N3 (Figure 
32, A2 and B2). This kind of binding mode is known to occur with cytidine.156  
Interestingly, when the duplex structure was made more flexible by introducing 





























































Figure 30. Suggested metal-ion-mediated base pairs between P and natural 




















Figure 31. Suggested metal-ion-mediated base pairs between Z and natural 




Figure 32. Suggested metal-ion-mediated base pairs between X and natural 





Zn2+ enhances the hybridization of ON1X and ON1Q with unmodified targets, 
but has a minor influence on hybridization of ON1P, ON1Y and ON1Z. ON1X 
shows selectivity towards A and C (as with Cu2+), whereas ON1Q exhibits 
equally high affinity to U, A, G and C containing targets. These findings are 
noteworthy as Zn2+-mediated base pairs have not been previously described. For 
example, the stability of a duplex DNA oligonucleotide containing a 3-
pyridine:2,6-pyridinedicarboxylate base pair (see Figure 14A and Table 4) was 
markedly increased by Cu2+, but none of the other metal ion studied, including  
Zn2+, had any effect.46 With hydroxypyridone homo-base pairs, as well as 
hydroxypyridone:pyridopurine base pairs (Figure 11B), stabilization by Zn2+ was 
observed but even in those cases the influence was much less than with Cu2+.157  
No clear evidence of duplex stabilization by Pd2+ was obtained with ON1X or 
ON1Y. The latter showed a modest increase in Tm with ON2A and ON2C. 
Perhaps the less bulky ON1Y is better compatible with relatively bulky Pd2+ ion.  
 
4.2 The influence of metal-ion-binding nucleoside in a 3´-terminal 
position on the duplex stability 
4.2.1 The effect of steric and stacking interactions 
Only 2,6-bis(3,5-dimethylpyrazol-1-yl)purine riboside (X) and 2-(3,5-
dimethylpyrazol-1-yl)adenine (Z) were studied as modified nucleoside analogues 
at the 3´-terminus. While replacement of a non-terminal A with either X or Z 
markedly destabilized the duplex in the absence of metal ions, the influence in 
3´-terminal position was the opposite. Z was more strongly stabilizing than X. 
Evidently the steric constraints for proper accommodation of the modified base 
into the double helical structure are now less demanding.26,39 The modified self-
complementary ORNs (all in ON4X series) give higher Tm values compared to 
their natural counterparts (ON4A), most likely due to enhanced stacking of the 
modified bases. With Z, the stabilization is more prominent than with X (Table 
10 and Figure 28). This  result is consistent with the observation  that the 
pyrazole ring on C2 is more favorable for stacking than the same group on C6 
(see section 4.1.1).  
    
4.2.2 The effect of metal-ion-mediated base pairing 
While X in a non-terminal position favored binding to C and A in the presence of 
Cu2+, it exhibited U/G-selectivity when situated in a terminal position. In other 






in a non-terminal position. The other modified nucleoside, Z, studied in a 
terminal position was also U/G-selective. In summary, the nucleosides being able 
to bind as anionic ligands seem again to be favored.  A possible reason for the 
different selectivity of X in terminal and non-terminal position is that the 
otherwise preferred binding mode is retarded in a non-terminal position due to 
difficulties in accommodating the relatively large base moieties within the base-
stack of a fully complementary double helix (Figure 4). Such constraints 
evidently are less stringent in a terminal position. It is worth noting that one 
mismatch on both sides of a non-terminal X abolishes the C/A-selectivity; 
addition of Cu2+ increases the Tm value 11-12 oC irrespective of the identity of 
the opposing base.  
The highly stabilizing influence of X in a terminal position is not limited to 
formation of 6-mer duplexes bearing a metallo base pair at both termini. The 
duplex that pentamer ON7X formed with a longer target ON23 experienced upon 
addition of Cu2+ an increase of 26 oC in the Tm value.  
The results obtained with Pd2+ ion, viz. the high stability of the Pd2+-mediated 
base pairs formed by the modified nucleoside X at the monomeric level, and the 
inability of Pd2+ to stabilize oligonucleotide duplexes containing the same 
residue, are puzzling. Maybe the inert Pd2+ binds too strongly to an unwanted 
place, wherein the thermodynamically most stable product [metallo base pair 
X:Pd:U(or C,A,G)] can not be formed, however the situation slightly improves at 
terminal position with 10 oC increase in Tm. Although many coplanar Pd2+-
chelated base pairs have been reported,81,86,158 attempts to stabilize ON duplexes 
with such base pairs have failed.  
  
4.3 Fluoresence spectrometric studies on probing RNA secondary 
structure by metal-ion-mediated base pairing  
Hybridization of short metal-ion-bonding 2´-O-Me-ORNs with longer target 
sequences containing a pyrrolo-dC fluorophore has been shown to be 
accompanied by marked quenching in the presence of Cu2+ in case the 
pyrrolocytosine base becomes engaged in double helix.   
Comparative melting temperature determinations have verified that, the drop of 
fluorescence intensity upon hybridization correlated well with the thermal 
stability of the duplex. Attempts to exploit these metal-ion-binding short ORNs 
for probing of RNA secondary structure have unfortunately been less successful. 
Marked fluorescence quenching was observed upon Cu2+-mediated binding of 




bulge contained pyrrolo-dC. The quenching was not, however, sufficiently 
quantitative to allow firm conclusions to be drawn, since addition of ORN probes 
in the absence of Cu2+ or addition of Cu2+ in the absence of ORN probe also 
markedly influenced on the fluorescence intensity.  Evidently the three unpaired 
bases of the bulge are not sufficient for efficient hybridization, even if one of the 

























Several Cu2+-mediated base pairs between two bidentate ligands and between one 
tridentate and one monodentate ligand have been introduced into ONs earlier by 
others. Markedly increased Tm values have, however, been reported only when 
both ligands are modified nucleosides.  
In our study, the 3,5-dimethylpyrazol-1-yl substituted purine derivatives 
incorporated into 2´-O-Me-ORNs exhibit different preferences in metal-ion-
mediated base pairing with natural nucleobases depending on the location of the 
pyrazolyl substituents. The duplex stability significantly dependent on whether 
the purine derivative is readily able to participate in the metal-ion-mediated base 
pair as an anionic ligand. Among all of the modified ORNs studied, this was the 
case with the ORN containing a 2-(3,5-dimethylpyrazol-1-yl)-6-oxopurine base. 
This was found in the presence of both Cu2+ and Zn2+ more efficiently than the 
other modified ORNs studied exhibiting some base-selectivity. 
While 2,6-bis(3,5-dimethylpyrazol-1-yl)purine riboside could not serve as 
anionic ligand, it still substantially enhanced duplex formation when situated at 
the 3´-terminus of the ORN. For example, the Tm value of duplexes of a 5-mer 
ORN with a longer target was increased by 23-26 oC upon addition of 1 equiv. of 
Cu2+. This increase of Tm for two terminal X:Cu:U and Z:Cu:U metal-ion-
mediated base pairs are respectively 33 oC and 30 oC more than the stabilization 
with natural A:U. Binding to U and G that may serve as anionic ligands was 
preferred over C and A. The base-selectivity reversed to favor C and A when 
bulky 2,6-bis(3,5-dimethylpyrazol-1-yl)purine riboside was situated in a non-
terminal position. The difficulty of accommodating  modification in the middle 
of a double helix was also evident from the results of fluorometric studies. When 
situated opposite to fluorescent pyrrole-dC, (3,5-dimethylpyrazol-1-yl)purine 
forced the pyrrolocytosine base to flip out, as evidenced by marked increase in 
fluorescence emission. Addition of Cu2+, however, resulted in formation of a 
Cu2+-mediated base pair: Tm was increased and fluorescence emission reduced.  
The results obtained with the TAR RNA models were not as clear as those 
obtained with simple duplexes and, therefore, hybridization of the metal-ion-
binding oligonucleotides with the desired target site could not be unambiguously 
established. It seems possible that even with the stabilizing effect of the metal-
ion-mediated base pair, the affinity of the modified oligonucleotides for the very 





6.1 General methods 
The modified nucleosides synthesized were characterized by micrOTOF-Q ESI-
MS, 1H NMR, 13C NMR and 31P NMR and HSQC (or COSY) spectrometry. The 
NMR spectra were recorded on a 400 or 500 MHz spectrometer and the chemical 
shifts are given in ppm. The oligonucleotide products were analysed by HPLC 
and micrOTOF-Q ESI-MS. All oligonucleotides were prepared on an Applied 
Biosystems 3400 DNA/RNA synthesizer by conventional phosphoramidite 
strategy. The synthetic methods for all compounds of this thesis are described in 
detail in the original publications (I-III).118-120,128 
 
6.2 Melting temperature studies 
The UV melting curves (absorbance versus temperature) were measured by 
monitoring the temperature dependence of the absorbance at 260 nm on a Perkin-
Elmer Lambda 35 UV-vis spectrophotometer equipped with a Peltier temperature 
controller. The temperature was changed at a rate of 0.5 °C min-1 from 10 to 90 
°C. The measurements were carried out at pH 7.4 in 20 mM cacodylate buffer 
and ionic strength of 0.10 M, adjusted with NaClO4. For all measurements the 
concentration of the oligonucleotides and CuSO4, Zn(NO3)2 or K2PdCl4 (where 
applicable) was 3 M. The Tm values were determined as maximum values of the 
first derivatives of the melting curves. 
 
6.3 CD measurements 
The CD spectra were acquired by an Applied Photophysics Chirascan 
Spectropolarimeter. The temperature range was from 6 to 94 °C and scan range 
was between 220 and 320 nm.  
 
6.4 Kinetic measurements 
The method of kinetic measurements is reported in detail in the original 
publication (III).119 The pseudo first-order rate constants for the disappearance of 
ON5Xa were obtained by applying the integrated first-order rate equation (Eq. 1) 







ln[A1/A2]t = -kt + ln[A1/A2]0     (1) 
The signal area for the starting material (A1) was normalized by dividing it with 
the signal area of the internal standard (A2) (potassium 4-nitrobenzenesulfonate).  
 
6.5 Fluorometric studies 
Fluorescence emission spectra were obtained using a Cary Eclipse fluorescence 
spectrophotometer between 400 and 600 nm with an excitation wavelength of 
337 (1 nm bandwidth). The scan rate of emission excitation spectra was 120 nm 
min-1 with a slit of 5 nm and a PMT voltage of 600 V. The concentration of 
oligonucleotides and CuSO4 or Zn(NO3)2 was 2.0 µM and sample buffer and 
conditions were the same as reported above for the Tm measurements. Before 
fluorescence measurements all samples were quickly heated to approximately 90 
°C and then allowed to slowly cool down in a standard 10 mm, 3.5 mL square 
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